Inflammatory Bowel Diseases
Information
- Disease name
- Inflammatory Bowel Diseases
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT04522271 | Active, not recruiting | N/A | Resistant Starch in Pediatric Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) | August 25, 2020 | May 1, 2024 |
NCT05374967 | Active, not recruiting | N/A | The Effect of a Multimodal Lifestyle Intervention on Chronic Fatigue in Patients With Inflammatory Bowel Disease | May 12, 2022 | April 1, 2024 |
NCT04520594 | Active, not recruiting | N/A | OptiMized REsistaNt Starch in Inflammatory Bowel Disease: The MEND Trial | March 3, 2021 | August 1, 2024 |
NCT04989907 | Active, not recruiting | A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Switzerland | September 8, 2021 | June 30, 2024 | |
NCT05221281 | Active, not recruiting | N/A | Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care | February 25, 2022 | December 31, 2025 |
NCT04147585 | Active, not recruiting | N/A | Effects of an Intermittent Reduced Calorie Diet on Crohn's Disease | December 18, 2019 | July 14, 2024 |
NCT06288061 | Active, not recruiting | N/A | Effectiveness of Non-invasive Phrenic Nerve Neuromodulation in Subjects With Inflammatory Bowel Disease and Neck Pain. | March 20, 2024 | July 4, 2025 |
NCT06261320 | Active, not recruiting | Phase 2 | Mesotherapy Treatment of Irritable Bowel Syndrome | February 28, 2024 | January 31, 2026 |
NCT05674773 | Active, not recruiting | Treatment Outcomes of Advanced Neoplasia in IBD | May 21, 2019 | July 1, 2023 | |
NCT06096987 | Active, not recruiting | N/A | Teen-to-Teen Videos to Improve Electronic Medical Record Portal Knowledge and Personal Health Information Engagement | July 13, 2021 | January 1, 2024 |
NCT05195502 | Active, not recruiting | Mapping the Human Colon Using Single Cell Sequencing | July 1, 2022 | July 1, 2024 | |
NCT04046913 | Active, not recruiting | N/A | The ADDapt Diet in Reducing Crohn's Disease Inflammation | September 9, 2019 | August 20, 2024 |
NCT03938324 | Active, not recruiting | N/A | Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions | October 29, 2019 | May 2024 |
NCT03829475 | Active, not recruiting | Phase 2 | ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDI | January 1, 2020 | March 1, 2024 |
NCT05000242 | Active, not recruiting | West Hertfordshire Inflammatory Bowel Disease Technology Study | January 31, 2022 | March 1, 2024 | |
NCT03798691 | Active, not recruiting | Phase 4 | Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab | May 28, 2019 | September 2024 |
NCT05291689 | Active, not recruiting | Phase 2 | A Phase 2a Open-Label Study to Evaluate the Efficacy and Safety of MORF-057 in Adults With UC | May 24, 2022 | February 2025 |
NCT00606346 | Active, not recruiting | A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease | May 31, 2007 | June 30, 2038 | |
NCT06113913 | Active, not recruiting | Phase 4 | Subcutaneous Infliximab After A Previous Intravenous Dose Optimization | April 9, 2024 | November 2026 |
NCT03000296 | Active, not recruiting | N/A | Autologous Unselected Hematopoietic Stem Cell Transplantation for Refractory Crohn's Disease | October 2013 | December 2024 |
NCT04959851 | Active, not recruiting | A Study on How Vedolizumab is Given and the Outcomes for Adults With Inflammatory Bowel Disease (VARIETY-Belgium) | December 2, 2021 | June 30, 2024 | |
NCT03038984 | Active, not recruiting | N/A | Are Rates of Colectomies, Resections, Mortalities and Cancer Reduced by Home Monitoring of IBD Patients ? | August 2016 | August 2026 |
NCT03487926 | Active, not recruiting | Microglial Activation in Inflammatory Bowel Disease | September 14, 2022 | December 31, 2024 | |
NCT03285230 | Active, not recruiting | The French E3N Prospective Cohort Study | June 15, 1990 | December 15, 2025 | |
NCT03266484 | Active, not recruiting | N/A | Effect of a Probiotic Mixture on the Gut Microbiome and Fatigue in Patients With Quiescent Inflammatory Bowel Disease | November 13, 2017 | July 2024 |
NCT04838834 | Active, not recruiting | Monitoring Serologic Response to Severe Acute Respiratory Syndrome-2 (SARS-COV-2)/COVID-19 in Children | May 15, 2020 | December 31, 2024 | |
NCT05572203 | Active, not recruiting | N/A | Phenotyping of Adult Crohn's Focusing on Sarcopenia | April 14, 2022 | December 1, 2023 |
NCT04565821 | Active, not recruiting | N/A | Feasibility Study to Assess a Trans-nasal Intestinal Potential Difference Probe | November 12, 2020 | April 30, 2027 |
NCT04990258 | Active, not recruiting | A 24-month Real Life PErsistence Efficacy and Safety Study in IBD Patients in REMission Switched From Intravenous Infliximab to Subcutaneous Infliximab CT-P13 Remsima®SC | September 6, 2021 | September 30, 2024 | |
NCT02238665 | Completed | CLE for Differential Diagnosis of IBD | October 2009 | September 2014 | |
NCT02302404 | Completed | Phase 1 | A Safety and Tolerability Study of GSK2982772, in Single (in Both Fed and Fasted States) and Repeat Oral Doses in Healthy Male Subjects | January 6, 2015 | March 5, 2016 |
NCT02316678 | Completed | Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics | September 2014 | December 2016 | |
NCT02330653 | Completed | Phase 1/Phase 2 | Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's Colitis | November 2015 | April 8, 2019 |
NCT02367326 | Completed | Identification of Scores Associated With a Favorable Clinical Response With Thiopurines in IBD Patients | June 2014 | August 2017 | |
NCT02376478 | Completed | On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection | December 2009 | January 2011 | |
NCT02407236 | Completed | Phase 3 | A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis | July 10, 2015 | November 30, 2021 |
NCT02445365 | Completed | N/A | Remote Ischemic Conditioning in Patients With Ulcerative Colitis | May 2015 | February 15, 2018 |
NCT02503514 | Completed | Autoimmune Paradoxical Reactions in IBD Longitudinal Cohort | August 2015 | August 2017 | |
NCT02521064 | Completed | Effects of Exclusive Enteral Nutrition on the Microbiome in Pediatric Inflammatory Bowel Disease | July 2015 | August 2016 | |
NCT02539368 | Completed | Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease | April 22, 2015 | October 31, 2018 | |
NCT02542917 | Completed | Home Versus Postal Testing for Faecal Calprotectin: a Feasibility Study | September 2015 | August 2016 | |
NCT02569333 | Completed | N/A | Patient Centered Algorithms to Optimize the Inpatient Experience and Treatment of Ulcerative Colitis | January 2016 | January 2020 |
NCT02647866 | Completed | Phase 2 | Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis | June 2016 | October 2018 |
NCT02796339 | Completed | Phase 2 | A Study on the Effectiveness of a Nutritional Supplement With Natural Mastiha in Inflammatory Bowel Diseases. | May 2016 | March 10, 2021 |
NCT02825914 | Completed | N/A | CAsein GLycomacropeptide in Ulcerative Colitis - Anti-Inflammatory and Microbiome Modulating Effects (CAGLUCIM) | September 1, 2016 | October 1, 2019 |
NCT02849717 | Completed | N/A | Pre-Habilitation Exercise Intervention | March 2016 | February 2023 |
NCT02861339 | Completed | N/A | Prevalence of Keratoconus in Inflammatory Bowel Diseases | February 2014 | July 2014 |
NCT02874365 | Completed | N/A | Intestinal Stem Cells Characterization | September 2016 | December 27, 2023 |
NCT02884557 | Completed | N/A | NKT Role in the Regulation of the Inflammatory Bowel Disease | May 2013 | August 28, 2019 |
NCT02899871 | Completed | Joint Pain Occurring During Anti-TNF Therapy in Chronic Inflammatory Bowel Disease | September 2014 | October 2016 | |
NCT02904590 | Completed | A Prospective Study on the Incidence and Risk Factors Related to Infection in Patients With Inflammatory Bowel Disease | October 2016 | ||
NCT02946203 | Completed | Phase 4 | Comparison of VoLumen and Breeza Oral Contrast Agents in Pediatric Patients | November 2016 | November 2017 |
NCT02985476 | Completed | N/A | Electronic Linkage for Inflammatory Bowel Disease to Deliver Joint Access to Health Reports | May 2010 | August 2011 |
NCT02986724 | Completed | A Study to Observe the Safety and Efficacy of Vedolizumab in Biologically Naive Participants With Ulcerative Colitis (UC) or Crohn´s Disease (CD) | January 4, 2017 | August 31, 2020 | |
NCT02991443 | Completed | N/A | Mindfulness Based Stress Reduction for Parents of Children With IBD | December 2016 | October 15, 2020 |
NCT03026582 | Completed | Intestinal Ultrasound in Pediatric Inflammatory Bowel Disease | July 1, 2017 | September 30, 2023 | |
NCT03056924 | Completed | Immunogenicity of Influenza, Pneumococcal and Hepatitis B Vaccines in IBD Patients Treated With Vedolizumab | July 5, 2017 | January 15, 2019 | |
NCT03059186 | Completed | N/A | A Gratitude Intervention in Improving Well-being and Coping in People Living With Inflammatory Bowel Disease | June 6, 2017 | June 1, 2018 |
NCT03082287 | Completed | ALPCO Calprotectin ELISA - Measurement of Calprotectin Levels in Human Stool | May 1, 2017 | October 25, 2019 | |
NCT03090139 | Completed | Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets | March 28, 2017 | June 13, 2018 | |
NCT00086554 | Completed | Collection of Specimens for Study of Inflammatory Bowel Disease | July 1, 2004 | January 8, 2010 | |
NCT00434551 | Completed | MACCS: Multicenter Australian CE in Patients With Suspected Crohn's Disease Study | February 2005 | February 2008 | |
NCT00521950 | Completed | N/A | Cost-effectiveness of TPMT Pharmacogenetics | September 2007 | December 2011 |
NCT00639821 | Completed | Mucosal Gene Expression Defects in IBD | July 2004 | February 2008 | |
NCT00720538 | Completed | Phase 3 | Thalidomide in Pediatric Inflammatory Bowel Diseases. | August 2008 | June 2012 |
NCT00721812 | Completed | Phase 1 | A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686 | September 25, 2008 | May 27, 2009 |
NCT00920400 | Completed | Diagnostic Value of Fecal Calprotectin in Disorders of the Upper Gastrointestinal Tract | March 2008 | December 2009 | |
NCT00955123 | Completed | Effects of Prednisolone and Infliximab on the Regulation of Urea Synthesis in Active Inflammatory Bowel Disease | January 2009 | December 2011 | |
NCT00982618 | Completed | N/A | Functional Restoration After Abdominal and Pelvic Laparoscopic Surgery: Effect of Perioperative Intravenous Lidocaine | July 2009 | June 2011 |
NCT01035645 | Completed | Phase 1 | First Time in Human Study of Intravenous Interleukin-18 Antibody | January 5, 2010 | July 11, 2012 |
NCT01056913 | Completed | Phase 4 | NITI CAR27 (ColonRing) Compression Anastomosis in Colorectal Surgery | October 2008 | September 2010 |
NCT01155440 | Completed | Phase 2 | Bowel Function After Laparoscopic Colon Surgery: Effect of IV Lidocaine | June 2009 | October 2011 |
NCT01173588 | Completed | Phase 3 | Effect of Yogurt Added With Bifidobacteria and Soluble Fiber on Bowel Function. | June 2007 | February 2008 |
NCT01216514 | Completed | Serologic Markers for Inflammatory Bowel Disease During Clinical Forms With Weak or Strong Evolution Capacities | October 2010 | July 2011 | |
NCT01430039 | Completed | Syndecan-1 a Surrogate Marker for IBD | October 2011 | April 2015 | |
NCT01477190 | Completed | Phase 1/Phase 2 | Spinal Analgesia for Colonic Resection Using an Enhanced Recovery After Surgery (ERAS) Program | October 2010 | October 2011 |
NCT01524328 | Completed | Complementary and Alternative Medicine in Patients With Inflammatory Bowel Disease. A Cross Sectional Study in Norway. | October 2009 | June 2011 | |
NCT01534312 | Completed | N/A | Casein Glycomacropeptide in Active Distal Ulcerative Colitis (Pilot Study) | January 2012 | December 2014 |
NCT01666717 | Completed | Characterization of Disease Related Changes in Inflammatory Bowel Disease Using Fecal Metabolite Profiling | August 2008 | May 2012 | |
NCT01828047 | Completed | Sublingual Microcirculation and Postoperative Ileus | November 2013 | November 2014 | |
NCT01838109 | Completed | N/A | Postoperative Oral Nutritional Supplementation After Major Gastrointestinal Surgery | April 2013 | April 2014 |
NCT01908283 | Completed | Phase 4 | Induction of Immunity Against Streptococcus Pneumoniae in Adults With Inflammatory Bowel Disease | March 2014 | December 2016 |
NCT01971970 | Completed | Biomarkers of Anti-TNF Treatment in Inflammatory Bowel Disease (IBD) | October 2013 | January 30, 2017 | |
NCT01974869 | Completed | Anti Tumor Necrosis Factor Alpha Agents and Surgical Stress Response | March 2014 | August 2016 | |
NCT01990716 | Completed | N/A | Lipid Mediators in Colonic Biopsies as Biomarkers of Disease Activity of Inflammatory Bowel Diseases | February 2013 | May 2015 |
NCT02009202 | Completed | N/A | Preparation Prior to Colonoscopy in Children | November 2012 | June 2014 |
NCT02076750 | Completed | Phase 1/Phase 2 | Weekly Vitamin D in Pediatric IBD | March 2013 | June 2014 |
NCT02131168 | Completed | Epidemiology of IBD in Hong Kong: An Inception Cohort and Follow up Study | January 2011 | March 2021 | |
NCT02150551 | Completed | Phase 1 | Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease | June 7, 2018 | September 5, 2018 |
NCT03106844 | Completed | Phase 1/Phase 2 | The ICON Study: Outcomes After FMT for Patients With IBD and CDI | August 1, 2017 | December 31, 2020 |
NCT03134508 | Completed | Population Based Evaluation of the Use of TNFα Antagonists in Pregnant Women With Inflammatory Bowel Diseases | March 2016 | April 2017 | |
NCT03140306 | Completed | N/A | CT Using MBIR in Crohn's Disease: Prospective Clinical Evaluation of Diagnostic Efficacy, Safety and Patient Outcome. | October 24, 2017 | January 1, 2019 |
NCT03143517 | Completed | Fecal Calprotectin Collection Protocol | April 19, 2017 | August 23, 2018 | |
NCT03154905 | Completed | The Role of Peripheral and Tissue Chitinase 3-like 1 Protein Levels as a Bio-marker in IBD | February 2012 | January 9, 2016 | |
NCT03161886 | Completed | N/A | A Treat-to-target Strategy Using Pan-enteric Capsule Endoscopy (PCE) in Paediatric Crohn's Disease (CD). | December 1, 2014 | January 10, 2017 |
NCT03165058 | Completed | Assessment of Colonic Epithelial Integrity With Mucosal Impedance | November 2016 | May 2019 | |
NCT03170622 | Completed | Evaluation of Faecal Volatile Organic Compounds in the Diagnosis of Paediatric Inflammatory Bowel Disease | October 2, 2017 | June 28, 2019 | |
NCT03173144 | Completed | Chronic Inflammatory Disease, Lifestyle and Treatment Response | September 21, 2017 | April 30, 2021 | |
NCT03177044 | Completed | N/A | Behavioural Treatment for Functional Bowel Symptoms in Inflammatory Bowel Disease | June 1, 2017 | December 31, 2021 |
NCT03228615 | Completed | N/A | IBD Shared Decision Making Intervention | September 1, 2017 | July 19, 2019 |
NCT03241992 | Completed | N/A | MyChart in Patients With Inflammatory Bowel Disease. | November 15, 2017 | January 20, 2019 |
NCT03247816 | Completed | Feraccru® Real World Effectiveness Study in Hospital Practice ( FRESH ) | August 14, 2017 | October 1, 2018 | |
NCT03248024 | Completed | An Explanatory Factors Analysis of Inflammatory Bowel Diseases(IBD's) Management Costs for Adults Patients Treated by Biotherapy and Followed at Nancy University Hospital | November 28, 2016 | February 7, 2017 | |
NCT03254784 | Completed | Phase 1 | A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation | September 13, 2017 | November 15, 2017 |
NCT03261414 | Completed | N/A | HYSTERIA Evaluation of Clinical HYpnosis After Surgical Resection for Crohn Disease on Post-operative Analgesia | May 27, 2015 | January 30, 2020 |
NCT03262649 | Completed | Manitoba Inflammatory Bowel Disease Cohort Study | March 1, 2002 | October 1, 2016 | |
NCT03262727 | Completed | Phase 1 | The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients | September 1, 2017 | December 19, 2017 |
NCT03266471 | Completed | Cytokines and Genes in Therapeutic Response in Crohn's Disease | October 13, 2017 | May 3, 2022 | |
NCT03270267 | Completed | Chronic Inflammatory Bowel Diseases (IBD) and School Absenteeism | September 1, 2016 | February 28, 2018 | |
NCT03277703 | Completed | Phase 2 | Flu Vaccine Response in Patients on Biologic Therapies | November 3, 2017 | January 1, 2020 |
NCT03282903 | Completed | The PRognostic Effect of Environmental Factors in Crohn's and Colitis | November 1, 2016 | March 20, 2022 | |
NCT03301311 | Completed | N/A | Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease | April 10, 2018 | September 8, 2020 |
NCT03378167 | Completed | Phase 1 | PediCRaFT: Pediatric Crohn's Disease Fecal Transplant Trial | December 1, 2018 | September 30, 2023 |
NCT03408249 | Completed | N/A | IBDoc® Canadian User Performance Evaluation | May 5, 2017 | August 22, 2017 |
NCT03445624 | Completed | Abdominal Ultrasound With Doppler and Peripheral Hemogram in Assesment Inflammatory Bowel Disease | July 1, 2018 | October 1, 2021 | |
NCT03452501 | Completed | Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients | August 26, 2018 | August 17, 2020 | |
NCT03456752 | Completed | Phase 2 | Perioperative Dexamethasone on Postoperative Outcome in IBD | June 1, 2018 | January 13, 2020 |
NCT03457571 | Completed | Clinical Observational Study: IBD Patients With Restless-legs-syndrome and Iron Deficiency Syndrome | February 1, 2014 | April 30, 2015 | |
NCT03486158 | Completed | N/A | The CalproSmartNOR Study - a New Clinical Tool for Monitoring Patients With Inflammatory Bowel Disease | March 15, 2018 | March 27, 2020 |
NCT03496441 | Completed | Microbiota-anastomotic Leak Among Colorectal Surgery Patients : Pilot Study | January 30, 2018 | April 1, 2018 | |
NCT03512327 | Completed | N/A | Autoimmune Protocol Diet and Inflammatory Bowel Disease | September 1, 2016 | December 10, 2016 |
NCT03515070 | Completed | Microbiome and Genetic Analysis of Familial IBD | May 9, 2018 | December 30, 2019 | |
NCT03531593 | Completed | Dose Effect Relationship of MTX and IBD | February 1, 2017 | May 31, 2018 | |
NCT03532932 | Completed | A Study to Evaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life Practice | July 20, 2018 | November 8, 2021 | |
NCT03536091 | Completed | Magnification Endoscopy and Electronic Chromoendoscopy in Patients With Inflammatory Bowel Disease | March 1, 2017 | July 1, 2018 | |
NCT03546868 | Completed | Phase 2 | Diagnostic Validity of [18F]FSPG PET for the Assessment of Disease Activity in Inflammatory Bowel Disease | August 14, 2018 | January 11, 2019 |
NCT03553472 | Completed | Identifying Young Inflammatory Bowel Disease Patients at Risk for Herpes Zoster | January 1, 2018 | May 31, 2019 | |
NCT03565263 | Completed | Functional Gastrointestinal Disorders in Pediatric IBD | April 3, 2018 | November 8, 2020 | |
NCT03565432 | Completed | Sick Leave, Work Disability and Quality of Life in Korean Patients With Inflammatory Bowel Diseases | March 9, 2018 | February 19, 2020 | |
NCT03590639 | Completed | Validation Study for Disability Assessment Functional of Patients With Inflammatory Diseases Intestinal Chronic (VALIDate) | April 23, 2018 | April 16, 2020 | |
NCT03630146 | Completed | N/A | iPeer2Peer Program for Adolescents With Inflammatory Bowel Disease | May 17, 2018 | March 16, 2022 |
NCT03644602 | Completed | N/A | Low FODMAPs Diet in Gastrointestinal Disorders | July 2016 | December 2016 |
NCT03653481 | Completed | N/A | Treating IBD With Inulin | October 29, 2018 | August 30, 2022 |
NCT03662646 | Completed | Circadian Rhythms in Patients With IBD or Celiac Disease Upon Diagnosis and Medical Follow-up | August 31, 2017 | December 31, 2022 | |
NCT03667586 | Completed | N/A | Group Cognitive Behavioral Therapy for IBD Patients | February 21, 2019 | May 31, 2022 |
NCT03668249 | Completed | A Study to Characterize Multidimensional Model to Predict the Course of Crohn's Disease (CD) | September 26, 2018 | September 16, 2019 | |
NCT03671980 | Completed | N/A | IBD Self-management Website and Home Faecal Calprotectin Monitoring | April 4, 2017 | June 30, 2018 |
NCT03689257 | Completed | Study to Evaluate the Epidemiology and the Characteristics "Omics" in Patients Recently Diagnosed of Inflammatory Bowel Disease in Spain | October 1, 2017 | April 1, 2020 | |
NCT03691155 | Completed | N/A | The Feasibility of Following the Crohn's Diet | July 8, 2018 | December 18, 2018 |
NCT03695783 | Completed | N/A | The IBD&me Randomized Controlled Trial | March 6, 2019 | May 14, 2021 |
NCT03719118 | Completed | N/A | Tailored Therapeutic Model According to the Expression of Genes in Inflammatory Bowel Disease Patients | January 1, 2016 | October 5, 2018 |
NCT03723447 | Completed | Phase 4 | Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®) | October 23, 2018 | October 29, 2019 |
NCT03725124 | Completed | Family Planning in Inflammatory Bowel Disease | July 26, 2018 | January 31, 2020 | |
NCT03750565 | Completed | Phase 1 | Multiple Dose Ethnobridging PK Study in Healthy Subjects | November 27, 2018 | February 13, 2019 |
NCT03751722 | Completed | Genetic an Functional Studies of Patient With Inflammatory Bowel Disease | February 2007 | April 10, 2017 | |
NCT03757533 | Completed | N/A | Health Coaching as a Tool for Improving Medication Adherence in Adult Patients With Inflammatory Bowel Disease | June 11, 2019 | July 21, 2023 |
NCT03763266 | Completed | N/A | Low Residue Diet During 3 Days vs 1 Day Prior Colonoscopy | December 6, 2018 | January 20, 2020 |
NCT03794765 | Completed | Phase 2 | Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitis | April 1, 2019 | April 4, 2020 |
NCT03799471 | Completed | Somatosensory Profiles in Individuals With Persistent Musculoskeletal Pain and Inflammatory Bowel Disease | February 26, 2019 | July 19, 2019 | |
NCT03831750 | Completed | N/A | Assessing the Effectiveness of a Stress Reduction Intervention in Inflammatory Bowel Disease (IBD) | February 22, 2019 | January 15, 2021 |
NCT03835780 | Completed | The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study | February 1, 2019 | December 1, 2019 | |
NCT03836612 | Completed | Healthcare Resource Utilisation, Common Mental Health Problems, and Infections in People With Inflammatory Bowel Disease | February 1, 2019 | November 1, 2019 | |
NCT03840707 | Completed | N/A | LIFEwithIBD: Living With Intention, Fullness and Engagement With Inflammatory Bowel Disease | May 27, 2019 | February 28, 2021 |
NCT03847753 | Completed | Exploring the Comorbidity Between Mental Disorders and General Medical Conditions | January 1, 2000 | January 31, 2020 | |
NCT03860532 | Completed | Phase 1 | Phase I Clinical Trial in Healthy Male Volunteers | September 2011 | December 2011 |
NCT03909542 | Completed | Malnutrition Associated With Complications After Ileostomy Reversal | March 2015 | March 5, 2018 | |
NCT03939117 | Completed | The IUSS Crohn's Study: A Feasibility Study | January 19, 2019 | March 9, 2020 | |
NCT03947931 | Completed | Russian Extremely Severe Ulcerative Colitis Study | June 20, 2019 | June 20, 2022 | |
NCT03952195 | Completed | Complications and Outcomes of Pouch Excision | November 1, 2015 | April 1, 2018 | |
NCT03967236 | Completed | Impact of Intestinal Virome on Pediatric Inflammatory Bowel Disease | July 10, 2019 | February 28, 2022 | |
NCT03998215 | Completed | N/A | Diphtheria Vaccination in Adolescents With Inflammatory Bowel Disease | December 1, 2012 | January 1, 2015 |
NCT03998449 | Completed | N/A | Immunogenicity of Cholera Vaccine in Children With IBD | August 30, 2017 | May 1, 2020 |
NCT03998488 | Completed | Phase 2 | Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis | January 31, 2020 | April 12, 2024 |
NCT04018040 | Completed | N/A | Vegetarian Diet in IBD | May 6, 2019 | August 10, 2023 |
NCT04045782 | Completed | Phase 4 | Evaluation of the Safety and Effectiveness of Switching From Humira® to Imraldi® in Flanders | August 19, 2019 | January 29, 2021 |
NCT04067778 | Completed | N/A | IBD Neoplasia Surveillance Pilot RCT | November 6, 2020 | October 6, 2022 |
NCT04083157 | Completed | Phase 2/Phase 3 | Intra-dermal With Topical Imiquimod Pretreatment Versus Intra-muscular Hepatitis B Vaccination in IBD Patients | August 12, 2019 | December 30, 2021 |
NCT04089501 | Completed | The Role of the Pregnane X Receptor (PXR) in Indole Signaling and Intestinal Permeability in Inflammatory Bowel Disease | February 25, 2015 | May 2, 2019 | |
NCT04132024 | Completed | N/A | Feasibility of Insomnia Tracking and Treatment in IBD | October 7, 2019 | April 15, 2021 |
NCT04151420 | Completed | Real Life Remote Monitoring of Mild, Moderate and Severe Infectious Complications in IBD by Patient Reported Assessment | June 15, 2020 | February 1, 2022 | |
NCT04159727 | Completed | N/A | Gut Microbiota Dysbiosis and Translocation During IBD and Parkinson | March 28, 2019 | February 13, 2020 |
NCT04188990 | Completed | N/A | Cost Effectiveness of an Intervention in Hospitalized Patients With Disease-related Malnutrition | June 15, 2020 | June 30, 2023 |
NCT04190108 | Completed | Frequency of Elevated Fecal Calprotectin Levels in Psoriatic Arthritis. | January 2, 2016 | October 31, 2019 | |
NCT04198831 | Completed | N/A | Effect of Acupuncture on Quiescent Crohn's Disease | April 1, 2015 | December 31, 2023 |
NCT04241029 | Completed | N/A | Boosting Biologics in UC | February 25, 2020 | December 15, 2023 |
NCT04254614 | Completed | N/A | Mobile Application for IBD Patients With Biologics | March 12, 2020 | February 1, 2021 |
NCT04256538 | Completed | Identify Specific Peripheral Blood Mononuclear Cell (PBMC) MiRNA as Biomarkers for Inflammatory Bowel Disease (IBD) | August 15, 2019 | June 30, 2020 | |
NCT04291976 | Completed | N/A | Back-to-back Endoscopy Versus Single-pass Endoscopy and Chromoendoscopy in IBD Surveillance | March 13, 2020 | November 7, 2023 |
NCT04294615 | Completed | N/A | Clinical Response and Safety Following FMT for UC | April 1, 2016 | March 31, 2018 |
NCT04296500 | Completed | A Development of Inflammatory Bowel Disease Pattern Identification Algorithm Using Case Series Data | November 1, 2007 | October 28, 2015 | |
NCT04304950 | Completed | Phase 4 | Chronotherapy in Inflammatory Bowel Disease | April 25, 2016 | April 2023 |
NCT04333810 | Completed | Remote Physiologic Monitoring to Detect Inflammatory Bowel Disease (IBD) Flares: A Feasibility Study | October 1, 2020 | July 31, 2023 | |
NCT04366544 | Completed | N/A | Effects of an 8-day Advanced Meditation, Samyama on Physical, Psychological and Spiritual Wellbeing ,and Associated Neural Mechanisms | January 19, 2018 | July 31, 2018 |
NCT04369963 | Completed | The Healthy Endoscopy Study | March 14, 2019 | February 5, 2022 | |
NCT04380922 | Completed | Prevalence of Periodontal Diseases in IBD | June 19, 2020 | June 10, 2022 | |
NCT04388865 | Completed | N/A | Patient Automated Text Hovering for IBD | February 23, 2021 | January 10, 2023 |
NCT04410484 | Completed | PREPARE-IBD: Physician Responses to Disease Flares and Patient Adaptation in Relation to Events in Inflammatory Bowel Disease During COVID-19 Pandemic | May 22, 2020 | August 31, 2022 | |
NCT04411017 | Completed | N/A | Protocol for Optimizing Colonoscopy Preparation in Patients With Inflammatory Bowel Disease | February 1, 2019 | July 20, 2021 |
NCT04411784 | Completed | PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis | May 20, 2020 | August 31, 2020 | |
NCT04457518 | Completed | Nutritional Status in Children With IBD | June 25, 2020 | October 30, 2020 | |
NCT04567628 | Completed | Study of Relationship Between Vedolizumab Therapeutic Drug Monitoring, Biomarkers of Inflammation and Clinical Outcomes | October 5, 2020 | September 22, 2021 | |
NCT04573959 | Completed | N/A | Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System | October 1, 2015 | June 11, 2020 |
NCT04589338 | Completed | N/A | Impact of Different Types of Physical Activity in Patients With Chronic Inflammatory Bowel Disease | January 5, 2021 | February 7, 2023 |
NCT04597905 | Completed | Paricipant Preferences in the Treatment of Inflammatory Bowel Disease (IBD) in Europe | October 21, 2020 | January 31, 2021 | |
NCT04637399 | Completed | Circadian Misalignment in Inflammatory Bowel Disease | November 22, 2016 | November 2021 | |
NCT04646785 | Completed | N/A | Mindfulness-based Cognitive Therapy for Patients With Inflammatory Bowel Disease | August 1, 2021 | October 3, 2023 |
NCT04693780 | Completed | N/A | Randomized Controlled Trial of Citizen-targeted Evidence-based Resources | April 19, 2021 | October 18, 2021 |
NCT04708405 | Completed | The Relationship Between Helicobacter Pylori Infection and Inflammatory Bowel Diseases: A Real-life Observation | September 10, 2019 | October 30, 2020 | |
NCT04717284 | Completed | N/A | A Self-compassion Intervention for Parents of Children With Inflammatory Bowel Disease (IBD) | April 20, 2021 | December 11, 2021 |
NCT04757181 | Completed | N/A | The Inflammatory Bowel Disease - Anti-Inflammatory Diet (IBD-AID) | February 1, 2017 | June 1, 2019 |
NCT04757935 | Completed | N/A | Yoga for Youth With IBD: a Pilot Feasibility Study | January 1, 2017 | May 31, 2017 |
NCT04771039 | Completed | Ocular Manifestations of Inflammatory Bowel Disease | January 1, 2013 | December 12, 2020 | |
NCT04796571 | Completed | N/A | Care Coordination and Proactive Care to Improve Utilization of Resources and Reduce Expenditure in High Risk Inflammatory Bowel Disease (IBD) Patients | January 1, 2019 | March 1, 2020 |
NCT04810572 | Completed | N/A | Nutraceutical Composition Containing Natural Products Derivatives on the Modulation of the Endocrine Neuroimmune Axis | May 20, 2021 | December 19, 2022 |
NCT04816812 | Completed | N/A | The IBD-FITT Study - Moderate-intensity Exercise for IBD Patients With Moderate Disease Activity | November 15, 2021 | May 31, 2023 |
NCT04820413 | Completed | N/A | Faecal Microbiota Transplantation From Normal Pouch Function Donor in the Treatment of Chronic Pouchitis | March 1, 2021 | March 15, 2022 |
NCT04828031 | Completed | Phase 1 | Vitamin D Regulation of Gut Specific B Cells and Antibodies Targeting Gut Bacteria in Inflammatory Bowel Disease | July 1, 2021 | July 1, 2023 |
NCT04835727 | Completed | N/A | Effect of Semi-vegetarian Diet in Inflammatory Bowel Disease Patients With Clinical Remission | January 21, 2020 | October 1, 2021 |
NCT04861597 | Completed | N/A | Digital Behavioral Interventions in Inflammatory Bowel Disease | November 1, 2021 | March 22, 2023 |
NCT04873700 | Completed | A Study of Moderate to Severe Inflammatory Bowel Disease, Including Ulcerative Colitis (UC) and Crohn's Disease (CD) | August 30, 2021 | May 17, 2022 | |
NCT04879914 | Completed | N/A | Analysis of Microbiota Changes Induced by Microencapsulated Sodium Butyrate in Patients With Inflammatory Bowel Disease | June 1, 2020 | September 30, 2022 |
NCT04885920 | Completed | A Study on Administration Choices of Vedolizumab and Outcomes for Adults With Inflammatory Bowel Disease (IBD) (VARIETY - CROATIA AND SLOVENIA) | February 22, 2022 | March 12, 2024 | |
NCT04890262 | Completed | A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real-World Practice | August 18, 2021 | June 30, 2023 | |
NCT04924543 | Completed | N/A | OPtical Diagnosis Training to Improve Dysplasia Characterisation in IBD | July 7, 2021 | April 30, 2022 |
NCT04939948 | Completed | Multi-factor Analysis of Psychological Disorders in IBD Patients | July 1, 2021 | October 1, 2021 | |
NCT04948723 | Completed | Vaccination Practices for Inflammatory Bowel Disease Patients in China With Gastroenterologists | July 1, 2017 | August 1, 2017 | |
NCT04968145 | Completed | N/A | Home To Stay: a Randomized Trial Evaluating a Post-discharge Mobile App for Elective Colorectal Surgery | July 19, 2017 | January 21, 2020 |
NCT04970849 | Completed | Survey Study About Endoscopy During COVID-19 Pandemic for IBD Doctors | July 15, 2021 | July 15, 2021 | |
NCT05071404 | Completed | Efficacy Assessment and Monitoring of Subcutaneous Infliximab Levels. | November 1, 2020 | February 1, 2021 | |
NCT05098600 | Completed | The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic | October 15, 2021 | December 20, 2022 | |
NCT05106738 | Completed | Phase Angle and Chronic Intestinal Inflammatory Diseases | June 1, 2021 | November 30, 2023 | |
NCT05115370 | Completed | Vaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19 | November 1, 2021 | January 14, 2022 | |
NCT05138770 | Completed | Phase 1 | Pharmacokinetics and Pharmacodynamics Clinical Study of VC005 Tablets in Healthy Subjects | November 18, 2021 | August 30, 2022 |
NCT05160077 | Completed | N/A | Optoacoustic Characterization of Postprandial Intestinal Blood Flow | November 23, 2021 | January 15, 2022 |
NCT05162339 | Completed | Inflammatory Bowel Disease and Thromboembolic Events | November 1, 2016 | April 30, 2020 | |
NCT05168917 | Completed | N/A | EURECA (EUropeanRElapseCAlprotectin) Study | June 2, 2017 | January 13, 2020 |
NCT05171153 | Completed | Analysis of Bone Quality in Adult Patients With Inflammatory Bowel Disease | October 1, 2021 | January 1, 2023 | |
NCT05171452 | Completed | Urinary PGE-MUM (PROSTAGLANDIN E-MAJOR URINARY METABOLITE) as Inflammatory Marker in Chronic Inflammatory Bowel Disease | October 3, 2019 | October 19, 2020 | |
NCT05172557 | Completed | N/A | IBD and Women's Health Wellness Program | April 14, 2022 | December 26, 2023 |
NCT05202418 | Completed | N/A | Stress in Inflammatory Bowel Disease | February 27, 2022 | January 13, 2024 |
NCT05206734 | Completed | Risk of Mental Health Conditions in Children and Young Adults With Inflammatory Bowel Disease and Influence on Health | January 5, 2022 | August 15, 2023 | |
NCT05241158 | Completed | N/A | Impact of Counselling and Visual Aid on Anxiety in Endoscopic Patients | August 16, 2018 | February 4, 2020 |
NCT05291039 | Completed | N/A | Infliximab and Adalimumab in Inflammatory Bowel Disease Patients. | January 1, 2022 | April 1, 2023 |
NCT05340764 | Completed | Phase 4 | Safety of Reduced Infliximab Infusion Time | August 1, 2020 | May 4, 2023 |
NCT05345054 | Completed | The Deep South Surgical Equity Research Network: Addressing Socioecological Determinants of Health | August 1, 2022 | August 12, 2023 | |
NCT05354752 | Completed | Phase 1 | Multiple-dose Escalation Clinical Study of VC005 Tablets in Healthy Subjects | June 18, 2022 | November 15, 2022 |
NCT05405855 | Completed | N/A | eLIFEwithIBD - Living With Intention, Fullness and Engagement With Inflammatory Bowel Disease (Online) | January 5, 2022 | October 15, 2022 |
NCT05439772 | Completed | Phase 4 | Examining the Effect of Ondansetron on Bowel Prep Success | January 1, 2021 | July 1, 2023 |
NCT05452187 | Completed | Evaluation of the Safety and Effectiveness of Direct-acting Antiviral Drugs in the Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease: National Multicenter Study | March 12, 2021 | December 20, 2021 | |
NCT05456763 | Completed | N/A | Butyrate in Pediatric Inflammatory Bowel Disease | June 2013 | June 2022 |
NCT05456776 | Completed | Azathioprine Linked With Impaired Intestinal Epithelial Postoperative Regeneration in Crohn's Disease | April 2014 | October 2019 | |
NCT05504915 | Completed | Real World Data on Vedolizumab Concentration and Outcomes in Inflammatory Bowel Disease (IBD) Patients Switching From Intravenous (IV) to Subcutaneous (SC) Vedolizumab in University Hospital Center Osijek | May 1, 2022 | May 31, 2023 | |
NCT05538026 | Completed | N/A | Effectiveness of Fecal Microbiota Transplantation as add-on Therapy in Mild-to-moderate Ulcerative Colitis | September 1, 2020 | January 10, 2022 |
NCT05642247 | Completed | Quantify the Value of Transmural Inflammation in the Treatment of Crohn's Disease With Ustekinumab:an Analysis Based on Imaging Science | July 1, 2022 | January 31, 2023 | |
NCT05706038 | Completed | Impact of Adalimumab Withdrawal or Continuation on Severity of COVID-19 and Risk of IMID Relapse | April 27, 2022 | October 31, 2022 | |
NCT05707429 | Completed | Sexual Function and Quality of Life Among Patients Suffering From Inflammatory Bowel Disease(Inactive Stage) | February 1, 2023 | February 1, 2024 | |
NCT05726097 | Completed | Phase 3 | Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure | February 1, 2023 | October 31, 2023 |
NCT05777616 | Completed | The Impact of Medication Belief on Adherence to Infliximab in Patients With Crohn's Disease | November 15, 2021 | December 28, 2021 | |
NCT05807971 | Completed | Phase 1 | Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATH-063 in Healthy Subjects | April 6, 2023 | February 8, 2024 |
NCT05927064 | Completed | Study Evaluating the Persistence, Efficacy and Tolerability of Methotrexate in Inflammatory Bowel Disease Patients | July 21, 2023 | January 12, 2024 | |
NCT06023667 | Completed | N/A | SMART-IBD App Trial | December 14, 2022 | December 28, 2023 |
NCT06069167 | Completed | Bowel Urgency in Inflammatory Bowel Disease | October 12, 2023 | March 22, 2024 | |
NCT06216223 | Completed | N/A | Laser Versus Surgery in Anal Diseases in Inflammatory Bowel Patients | September 5, 2023 | April 5, 2024 |
NCT06270277 | Completed | N/A | Evaluation of Quality of Life and Psychosocial Status in Children With Inflammatory Bowel Disease | February 14, 2024 | February 21, 2024 |
NCT06274996 | Completed | Efficacy and Safety Analysis of Upadacitinib in Inflammatory Bowel Disease | January 1, 2021 | December 31, 2023 | |
NCT06429488 | Completed | Obsessive-compulsive Disorder, Depression and Anxiety Among Patients With Crohn's Disease | September 1, 2022 | September 1, 2023 | |
NCT03162549 | Enrolling by invitation | Corrona Inflammatory Bowel Disease (IBD) Registry | March 27, 2017 | December 2100 | |
NCT02952131 | Enrolling by invitation | Phase 1/Phase 2 | Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease | November 2016 | June 19, 2025 |
NCT04191655 | Enrolling by invitation | N/A | High Definition Colonoscopy (HDC) vs. Dye Spraying Chromo-colonoscopy (DSC) in Screening Patients With Long-standing Inflammatory Bowel Disease (IBD) | April 3, 2019 | December 2025 |
NCT03861689 | Enrolling by invitation | N/A | Tight Control Management in Perianal Crohn's Disease | July 1, 2019 | June 30, 2024 |
NCT03369353 | Enrolling by invitation | Precision Diagnostics in Inflammatory Bowel Disease, Cellular Therapy and Transplantation (The PREDICT Trial) | May 1, 2017 | January 2030 | |
NCT04835506 | Enrolling by invitation | Phase 4 | Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trial | November 1, 2021 | December 31, 2024 |
NCT04633512 | Enrolling by invitation | N/A | Safety and Feasibility of ActivSightTM in Human | November 17, 2020 | January 2025 |
NCT03228095 | Enrolling by invitation | Volatiles in Breath and Headspace Analysis - Diagnostic Markers | July 24, 2017 | December 31, 2025 | |
NCT06015789 | Enrolling by invitation | Self-care in Patients Affected by Inflammatory Bowel Disease and Caregivers' Contribution to Self-care | September 4, 2023 | October 1, 2024 | |
NCT04646187 | Enrolling by invitation | Phase 4 | De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease | March 11, 2021 | March 2025 |
NCT03756649 | Enrolling by invitation | Mayo Clinic IBD Biobank | November 1, 2018 | December 2065 | |
NCT05994716 | Enrolling by invitation | N/A | Telemonitoring for IBD Goodness Examination in Russia | April 25, 2023 | October 30, 2024 |
NCT02791854 | Enrolling by invitation | Improving the Quality of Care for Adults With Inflammatory Bowel Disease | February 26, 2016 | December 2030 | |
NCT05738915 | Not yet recruiting | Role of C-Reactive Protein /Albumin Ratio in Evaluation of Disease Activity in Patients With Inflammatory Bowel Disease | February 15, 2023 | August 15, 2023 | |
NCT05014555 | Not yet recruiting | Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease | July 5, 2023 | January 2024 | |
NCT06224270 | Not yet recruiting | Phase 4 | Study of Response to Zoster Vaccine in Adults With Inflammatory Bowel Disease Treated With Medications | June 2024 | July 2027 |
NCT06186999 | Not yet recruiting | Social and Demographic Determinants of Fatigue in Patients With Inflammatory Bowel Disease in Remission | January 1, 2024 | September 16, 2024 | |
NCT06179563 | Not yet recruiting | N/A | TOD-IBD: Empowering Patients On-Demand | March 1, 2024 | March 1, 2026 |
NCT06338930 | Not yet recruiting | N/A | Remote Monitoring of Patients With an Inflammatory Bowel Disease Under no or Maintenance Therapy | July 1, 2024 | March 30, 2027 |
NCT05482932 | Not yet recruiting | Health-related Physical Fitness in Patients With Inflammatory Bowel Disease | August 1, 2022 | April 1, 2024 | |
NCT05719766 | Not yet recruiting | N/A | Effect of Incentive Integrated E-IBD Chronic Disease Management Model on the Quality of Life in IBD Patients | April 1, 2023 | February 1, 2027 |
NCT05877209 | Not yet recruiting | Screening of Nutritional Status and Sarcopenia Among Patients With IBD | June 15, 2023 | December 1, 2023 | |
NCT06315179 | Not yet recruiting | Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE) | April 2024 | January 2030 | |
NCT06123052 | Not yet recruiting | A Qualitative Study on Patients' (un)Ability and (un)Willingness to Use Telemonitoring in Inflammatory Bowel Diseases | February 2024 | August 2024 | |
NCT06439641 | Not yet recruiting | N/A | Prevalence and Factors Associated With Sleep Disorders in Inflammatory Bowel Disease | July 2024 | September 2025 |
NCT06061432 | Not yet recruiting | N/A | Endoscopic Ultrasound- Guided Hartmann Reversal Procedure | December 1, 2023 | December 31, 2026 |
NCT06382519 | Not yet recruiting | Thalidomide Therapy for VEOIBD | May 15, 2024 | December 31, 2026 | |
NCT04647578 | Not yet recruiting | Physical Fitness Levels in Children and Adolescents With Chronic Inflammatory Bowel Disease (CIBD): Crohn's Disease, Ulcerative Colitis, Chronic Unclassified Colitis | December 2022 | July 2024 | |
NCT06066866 | Not yet recruiting | Microbiome Sampling in GI Disease With a Focus on Small Intestinal Microbial Assessment | January 1, 2024 | January 1, 2028 | |
NCT06309472 | Not yet recruiting | Phase 2 | Trial of Mirtazapine for Depression in IBD | March 2024 | June 2026 |
NCT06353633 | Not yet recruiting | N/A | The Effect of Exclusion Diet for Crohn's Disease Plus Enteral Nutrition on Children and Adolescents With Crohn's Disease | April 10, 2024 | December 25, 2024 |
NCT05810805 | Not yet recruiting | Measurement and Analysis of Gas Composition in Digestive Tract | April 1, 2023 | March 2, 2024 | |
NCT05455762 | Not yet recruiting | N/A | The Efficacy of Exercise Therapy in Patients With Inflammatory Bowel Disease | July 2022 | November 2022 |
NCT06309017 | Not yet recruiting | N/A | Pre-operative Nutrition for Elective Resection Surgery in Inflammatory Bowel Disease | March 10, 2024 | April 2025 |
NCT05689892 | Not yet recruiting | N/A | Shared Decision Making in Paediatric Inflammatory Bowel Disease | January 2024 | December 2025 |
NCT06301477 | Not yet recruiting | N/A | PRecisiOn Microbiome Directed ExtensiOn of Anti-TNFα Crohn's Disease ThErapy in Children: The PROMOTE Trial | April 1, 2024 | March 1, 2027 |
NCT05663671 | Not yet recruiting | Evaluate Established Anti-DEFA5 mAbs Diagnostic Efficacy and Safety in IBD | June 1, 2023 | June 30, 2025 | |
NCT05406934 | Not yet recruiting | Evaluation of Blood Platelet Indices,Platelet Aggregation in the Activity of IBD Patients on Biological Treatment | June 5, 2022 | October 2024 | |
NCT06287671 | Not yet recruiting | Colorectal Omics and ofCS Proteoglycans | April 2024 | December 2032 | |
NCT05332639 | Not yet recruiting | N/A | Personalized Risk Estimation for Crohn's Disease (PRE-CD): Implementation and Feasibility | February 2025 | August 2026 |
NCT04290156 | Not yet recruiting | N/A | The Effect of Joint Transition Visits on Quality of Life in Inflammatory Bowel Diseases (TRANS-IBD) | April 1, 2020 | November 1, 2024 |
NCT05920187 | Not yet recruiting | N/A | Dietary Intervention for Inflammatory Bowel Disease Remission | July 15, 2023 | January 1, 2026 |
NCT06427135 | Not yet recruiting | N/A | A Multimodal Wearable Device-based Study to Evaluate the Efficacy of an Exercise Prescription Intervention in IBD | July 1, 2024 | December 31, 2025 |
NCT05967650 | Not yet recruiting | N/A | Efficacy of Accelerated Versus Standard Regiment of Hepatitis B Virus Vaccine Among Inflammatory Bowel Disease Patients | September 1, 2023 | October 1, 2024 |
NCT05636657 | Not yet recruiting | Comparative Study of Intestinal Color Ultrasound and Capsule Endoscopy in Monitoring Crohn's Disease | November 30, 2022 | May 31, 2025 | |
NCT06453317 | Not yet recruiting | Phase 2 | Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis | July 2024 | June 30, 2028 |
NCT06274554 | Not yet recruiting | Phase 3 | Testing the Role for Anti-fungal Therapy in Improving the Response to Medicine for Crohn's Disease | June 2024 | December 2029 |
NCT06449820 | Not yet recruiting | Janus Kinase Inhibitors for the Treatment of Acute Severe Ulcerative Colitis | May 30, 2024 | June 30, 2024 | |
NCT06274294 | Not yet recruiting | Phase 3 | Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous as Induction Therapy in Patients With Active CD or UC | March 2024 | January 2025 |
NCT05610527 | Not yet recruiting | N/A | Hormonal Influences on Inflammatory Bowel Diseases | December 1, 2024 | March 1, 2027 |
NCT06424769 | Not yet recruiting | N/A | Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management | May 2024 | September 2028 |
NCT05598346 | Not yet recruiting | Significance of MAIT Cells in Inflammatory Bowel Disease | March 1, 2023 | April 2024 | |
NCT03422861 | Not yet recruiting | N/A | Nabilone Use For Acute Pain in Inflammatory Bowel Disease Patients | December 2023 | December 2024 |
NCT06342011 | Not yet recruiting | N/A | Effect of Anti-inflammatory Diet in Patients With Inflammatory Bowel Disease | May 1, 2024 | December 31, 2025 |
NCT06256393 | Not yet recruiting | Inflammatory Bowel Disease Cohort in Nantes | March 2024 | March 2030 | |
NCT05725369 | Not yet recruiting | The Effects of Combined Lifestyle Intervention (CLI) in Patients With Inflammatory Bowel Disease (IBD) | February 1, 2023 | February 1, 2025 | |
NCT06016322 | Not yet recruiting | N/A | Dried Chicory Root in IBD | October 2, 2023 | September 30, 2024 |
NCT05852587 | Not yet recruiting | Phase 1 | Xylitol Use for Decolonization of C. Difficile in Patients With IBD | January 1, 2025 | January 1, 2033 |
NCT06249763 | Not yet recruiting | N/A | Effects of Gluten Free Diet in Ulcerative Colitis | February 2024 | May 2025 |
NCT06453720 | Not yet recruiting | Predicting IBD Treatment Outcomes With Gut Microbiome Analysis | June 7, 2024 | December 7, 2025 | |
NCT06245278 | Not yet recruiting | N/A | The Effect of Non-Surgical Periodontal Therapy on Inflammatory Bowel Disease | February 1, 2024 | March 1, 2025 |
NCT05916274 | Recruiting | N/A | Exploration of the Activity of DNA Located Outside of Cellular Nucleus to Amplify Inflammation in Inflammatory Bowel Disease in Children Through Biological Pathway Cyclic GMP-AMP Synthase (cGAS) - Stimulator of Interferon Genes (STING) | May 31, 2023 | June 2026 |
NCT03972956 | Recruiting | Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease | December 23, 2020 | December 23, 2026 | |
NCT06421116 | Recruiting | Validation of a Preclinical Model Based on Patient-derived Organoids for the Study of the Gut-joint Axis in Spondyloarthritis | March 7, 2024 | December 31, 2025 | |
NCT05781698 | Recruiting | Phase 2 | Repurposing Fenofibrate in Modulating mTOR/NLRP3 Inflammasome in Patients With Ulcerative Colitis | March 20, 2023 | December 20, 2024 |
NCT05781737 | Recruiting | Inflammatory Bowel Disease and Atherosclerosis Development | November 1, 2022 | January 30, 2025 | |
NCT05797207 | Recruiting | N/A | Evaluation of the Diagnostic Potential of Artificial Intelligence-assisted Fecal Microbiome Testing for Inflammatory Bowel Disease | April 10, 2023 | December 31, 2024 |
NCT05809999 | Recruiting | N/A | IBD Neoplasia Surveillance RCT | September 23, 2022 | February 28, 2026 |
NCT05810155 | Recruiting | Delayed Surgery in Inflammatory Bowel Disease | January 8, 2023 | January 2026 | |
NCT04136587 | Recruiting | N/A | The Bacterial Secretome in IBD | June 1, 2019 | December 2025 |
NCT05838196 | Recruiting | N/A | Service Development of POCUS in the IBD Clinic | April 24, 2023 | November 1, 2024 |
NCT04178408 | Recruiting | IBD Registry in a Sub-Saharan African Population | January 2, 2021 | December 31, 2025 | |
NCT04187820 | Recruiting | N/A | Effect of Acupuncture on Mild to Moderate Active Crohn's Disease | June 1, 2019 | December 31, 2024 |
NCT05882006 | Recruiting | Gallstones and Risk of Inflammatory Bowel Disease | May 21, 2023 | January 1, 2024 | |
NCT04191395 | Recruiting | Evolution and Treatments of Chronic Inflammatory Systemic Diseases | December 11, 2019 | December 2029 | |
NCT05886322 | Recruiting | Remote Monitoring of IBD | June 7, 2022 | June 2024 | |
NCT04211129 | Recruiting | N/A | Effect of Acupuncture on Patients With Crohn's Disease in Remission | July 1, 2019 | December 31, 2024 |
NCT04223518 | Recruiting | Early Phase 1 | Serum Bovine Immunoglobulin (SBI) in Children and Young Adults With Inflammatory Bowel Disease (IBD) | September 20, 2020 | May 31, 2023 |
NCT05906043 | Recruiting | N/A | A Multidisciplinary Approach to Assessing and Treating Fatigue in Inflammatory Bowel Disease | June 20, 2023 | August 24, 2025 |
NCT05912387 | Recruiting | Early Phase 1 | Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study | May 31, 2023 | December 31, 2025 |
NCT04280510 | Recruiting | Pathogenic Study of Adult Immune Enteropathies | February 27, 2020 | February 27, 2028 | |
NCT05986136 | Recruiting | Phase 2/Phase 3 | Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease | August 20, 2023 | July 20, 2028 |
NCT05986903 | Recruiting | Influence of HLA-DQA1*05 Genotype in Adults With Anti-TNF Treatment With Proactive Therapeutic Drug Monitoring. | January 11, 2023 | January 1, 2025 | |
NCT05987501 | Recruiting | N/A | Multimodal Ultrasound in Inflammatory Bowel Diseases | December 1, 2019 | December 2024 |
NCT05988528 | Recruiting | Phase 2/Phase 3 | Clinical Study to Evaluate the Possible Efficacy of Nifuroxazide in Patient With Ulcerative Colitis | August 20, 2023 | November 20, 2028 |
NCT05998577 | Recruiting | N/A | A Personalized Approach to Abdominal Pain in Irritable Bowel Syndrome | May 19, 2023 | May 19, 2025 |
NCT04401605 | Recruiting | N/A | Fermented Food-Supplemented Diet in Ulcerative Colitis | September 14, 2020 | June 2025 |
NCT06002074 | Recruiting | N/A | SMART Program Impact on Quality of Life in Inflammatory Bowel Diseases | September 28, 2023 | August 2024 |
NCT04431700 | Recruiting | N/A | Study of Dietary Composition in Crohn's Disease | October 5, 2020 | May 1, 2025 |
NCT04504136 | Recruiting | N/A | Regulation of Mucosal Healing in Inflammatory Bowel Disease | April 30, 2021 | May 1, 2025 |
NCT04513015 | Recruiting | N/A | Markers of Oxidative Stress in Inflammatory Bowel Diseases: Risk Factors and Implications for a Dietetic Approach | December 15, 2019 | December 8, 2023 |
NCT06030882 | Recruiting | N/A | Improving Patient Outcomes Through the Implementation of an IBD Biologic Care Pathway | March 25, 2024 | March 2025 |
NCT06033469 | Recruiting | Therapeutic Monitoring of Infliximab and Adalimumab | March 15, 2018 | June 30, 2024 | |
NCT06042387 | Recruiting | Diverse Ancestry Study in IBD | May 1, 2022 | September 2027 | |
NCT06055543 | Recruiting | Phase 4 | Impact of a New Plant-based High-energy Oral Nutritional Supplement on Nutritional Outcomes in Malnourished Patients | August 9, 2023 | May 31, 2024 |
NCT04601805 | Recruiting | Optical Coherence Tomography Angiography Assessment of Retinal Lesions in Inflammatory Bowel Diseases | April 13, 2021 | December 29, 2024 | |
NCT04617184 | Recruiting | Registry and Biorepository for IBD in Central Texas | June 1, 2021 | December 31, 2030 | |
NCT06065228 | Recruiting | Therapeutic Endpoint in Pediatric IBD Conditions | November 27, 2023 | December 2025 | |
NCT04663971 | Recruiting | Fertility and Pregnancy After Surgery IBD Audit | February 1, 2024 | October 1, 2024 | |
NCT06065995 | Recruiting | N/A | StoMakker Mobile Application | September 30, 2022 | December 31, 2025 |
NCT04700917 | Recruiting | N/A | Internet-Based Cognitive Behavioural Program for Managing Stress With IBD: An RCT | March 16, 2021 | December 2024 |
NCT04722757 | Recruiting | N/A | Comparison of Functional Outcomes Between Transanal and Laparoscopic vs Open Ileal Pouch-Anal Anastomosis | January 1, 2021 | June 30, 2025 |
NCT04748627 | Recruiting | Global IBD Visualization of Epidemiology Studies (GIVES) in the 21st Century | October 1, 2021 | December 2023 | |
NCT06094608 | Recruiting | N/A | IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms | February 1, 2024 | May 31, 2026 |
NCT04760964 | Recruiting | Mitochondrial DAMPs as Mechanistic Biomarkers of Mucosal Inflammation in Crohn's Disease and Ulcerative Colitis | January 27, 2021 | December 31, 2025 | |
NCT06106607 | Recruiting | N/A | Physical Activity and Sedentary Behaviour in Patients With Inflammatory Bowel Disease | November 15, 2023 | August 31, 2024 |
NCT04782544 | Recruiting | N/A | Ganglioside and IBD | June 28, 2021 | September 15, 2023 |
NCT06107179 | Recruiting | Monitoring of Pediatric Inflammatory Bowel Diseases Using Multispectral Optoacoustic Tomography | January 24, 2024 | February 1, 2026 | |
NCT04799496 | Recruiting | A Study of Kynteles Injection (Vedolizumab) in Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease or Chronic Pouchitis | June 10, 2020 | January 14, 2026 | |
NCT06116331 | Recruiting | The Mind-Body IBD Study: Understanding the Mind-body Connection in IBD | April 1, 2023 | December 31, 2024 | |
NCT06124833 | Recruiting | Integrated Gut Microbiome Data in Inflammatory Bowel Disease | October 4, 2023 | August 1, 2028 | |
NCT06146816 | Recruiting | N/A | The Assessment of Infrared Treatment for Crohn's Disease | September 12, 2023 | April 2026 |
NCT04844606 | Recruiting | Phase 3 | A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) | May 26, 2021 | July 30, 2030 |
NCT06165029 | Recruiting | IUS Combined With VAT Predicts Anti-TNF-α Efficacy in Patients With IBD: a Prospective Study | November 22, 2023 | March 30, 2025 | |
NCT06186752 | Recruiting | N/A | Feasibility Test of Action Planning in Pediatric IBD | February 5, 2024 | September 2025 |
NCT06188793 | Recruiting | N/A | Virtual Reality (VR) -Directed Brain Gut Behavioral Treatment (BGBT) for Inflammatory Bowel Disease (IBD) Inpatients | February 13, 2024 | July 2025 |
NCT04896684 | Recruiting | Chronic Intestinal Pathologies Analytical Cohort at TouLouse | April 29, 2021 | September 2025 | |
NCT04916067 | Recruiting | N/A | Stoma Closure and Reinforcement Trial ll | December 1, 2021 | June 15, 2025 |
NCT04923100 | Recruiting | Therapeutic Effect of New Biologics in Crohn's Disease | June 10, 2021 | March 29, 2025 | |
NCT06201793 | Recruiting | Phase 2 | Minocyclin in Ulcerative Colitis as Added on Therapy | January 22, 2024 | August 20, 2028 |
NCT06206811 | Recruiting | Phase 1 | Phase 1 Study to Investigate OD-07656 in Healthy Adult Participants | February 12, 2024 | October 2025 |
NCT06447870 | Recruiting | Research on the Mechanisms of Treatment Non-response in Inflammatory Bowel Disease Based on Multi-omics Technology | December 1, 2023 | December 1, 2025 | |
NCT04960826 | Recruiting | Study of an Environmental Risk Factor in Crohn's Disease | September 27, 2021 | July 2023 | |
NCT06223347 | Recruiting | Improved and Simplified Staining Technique for Dysplasia Detection in Colitis | January 2024 | April 2026 | |
NCT04970446 | Recruiting | Phase 2/Phase 3 | Microbial Restoration in Inflammatory Bowel Diseases | December 1, 2021 | December 1, 2025 |
NCT02308917 | Recruiting | The Canadian Children Inflammatory Bowel Disease Network (CIDsCaNN) | September 2013 | April 1, 2026 | |
NCT04991324 | Recruiting | Phase 3 | Cholecalciferol Comedication in IBD - the 5C-study | September 21, 2022 | September 2024 |
NCT04995224 | Recruiting | Mechanism of Chronic Pain in Patients With IBD | October 18, 2021 | June 1, 2024 | |
NCT05003947 | Recruiting | Phase 1 | Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IBD | June 11, 2022 | October 2025 |
NCT05040854 | Recruiting | Can we Rely on HLA to Predict Resistance to Biological Therapy in IBD Patients | July 1, 2021 | July 1, 2024 | |
NCT06226883 | Recruiting | Phase 2 | A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease | April 4, 2024 | April 2028 |
NCT06255834 | Recruiting | Phase 1 | Phase 1 Study for IPG11406 in Health Volunteer | February 24, 2024 | December 30, 2024 |
NCT05130983 | Recruiting | Phase 1 | Study of ExoFlo for the Treatment of Medically Refractory Crohn's Disease | January 23, 2023 | September 1, 2024 |
NCT05158517 | Recruiting | VeDOlizumab PERsistence in IBD Patients After Switching From Intravenous to Subcutaneous Administration : a Real-life Multicenter Study (DOPER) | March 20, 2022 | March 20, 2025 | |
NCT06266104 | Recruiting | N/A | Image Enhanced Endoscopy IBD | April 3, 2024 | March 1, 2026 |
NCT06266663 | Recruiting | Social Determinants of Health, Medication Use, and Quality of Life in Inflammatory Bowel Disease | April 26, 2024 | December 2024 | |
NCT06269185 | Recruiting | Comparison Between Infliximab and Adalimumab on Patients With Ulcerative Colitis | March 6, 2024 | March 1, 2025 | |
NCT05176366 | Recruiting | Phase 1 | Study of ExoFlo for the Treatment of Medically Refractory Ulcerative Colitis | December 19, 2022 | September 1, 2024 |
NCT05176795 | Recruiting | Host-microbiota-environment Interactions | March 16, 2022 | September 2026 | |
NCT05180175 | Recruiting | Phase 4 | The Nordic IBD Treatment Strategy Trial | February 7, 2022 | July 10, 2024 |
NCT05183256 | Recruiting | Cohort of Inflammatory Bowel Disease Patient in Yeouido St. Mary's Hospital | October 26, 2020 | August 25, 2025 | |
NCT05185609 | Recruiting | Assessment of Anorectal Function in Patients With Inflammatory Bowel Disease | September 1, 2021 | December 30, 2027 | |
NCT05196958 | Recruiting | N/A | Interest of GLP1 Analogues in Overweight Type 2 Diabetic Patients With Chronic Inflammatory Bowel Disease | January 25, 2022 | December 31, 2024 |
NCT05209061 | Recruiting | Mapping the Human Appendix Using Single Cell Sequencing | February 1, 2023 | June 1, 2024 | |
NCT05211518 | Recruiting | N/A | Prevention of Inflammatory Bowel Diseases in Persons at Risk The PIONIR (Preventing IBD Onset in Individuals at Risk) Trial | May 4, 2021 | September 1, 2024 |
NCT05224193 | Recruiting | ACTIVE-IBD Study: Physical Activity and Sleep in Paediatric Inflammatory Bowel Disease | November 1, 2021 | September 1, 2026 | |
NCT05230875 | Recruiting | Sexual Dysfunction Among Inflammatory Bowel Disease Adults-Clinical Trial | April 7, 2022 | September 5, 2023 | |
NCT06281392 | Recruiting | N/A | Artificial Intelligence and Dysplasia Detection in Inflammatory Bowel Disease (EIIDISIA Study) | November 15, 2023 | November 15, 2026 |
NCT05251415 | Recruiting | Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases | April 4, 2022 | April 4, 2032 | |
NCT05280405 | Recruiting | Phase 4 | Early Proactive Therapeutic Drug Monitoring of Infliximab in Children: EPIC Study | March 9, 2022 | January 31, 2025 |
NCT06286709 | Recruiting | Phase 2 | FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis | March 27, 2024 | July 29, 2026 |
NCT05316584 | Recruiting | N/A | A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy | September 6, 2022 | December 31, 2024 |
NCT06299423 | Recruiting | N/A | Perioperative Monitoring to Assess Preoperative Anxiety in Inflammatory Bowel Disease Patients | November 22, 2023 | November 30, 2025 |
NCT01280825 | Recruiting | The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing | January 14, 2011 | December 14, 2027 | |
NCT05382897 | Recruiting | Early Phase 1 | Fasting-mimicking Diet in Treatment of Depressive Symptoms in IBD | July 1, 2022 | December 2024 |
NCT06300541 | Recruiting | Prevalence and Impact of Sarcopenia in Patients With Inflammatory Bowel Disease | April 1, 2021 | December 1, 2027 | |
NCT05413941 | Recruiting | N/A | Internet-based Cognitive Behavioral Therapy in Inflammatory Bowel Disease | September 26, 2022 | June 2025 |
NCT05425901 | Recruiting | N/A | Preclinical Evaluation of Multimodal Therapeutic Strategies in Intestinal Irradiation and Inflammatory Bowel Disease From Organoids | September 19, 2022 | September 18, 2025 |
NCT05456893 | Recruiting | A Study to Evaluate Biomarkers in Moderate to Severe Ulcerative Colitis (UC) Patients Treated With Different Targeted Therapies | July 28, 2022 | September 9, 2027 | |
NCT05456932 | Recruiting | Phase 4 | Predicting Response to Iron Supplementation in Patients With Active Inflammatory Bowel Disease | August 19, 2022 | August 31, 2023 |
NCT03251118 | Recruiting | A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease | July 24, 2017 | July 2025 | |
NCT03261102 | Recruiting | N/A | TDM Guided Early Optimization of ADAL in Crohn's Disease | January 17, 2017 | June 1, 2024 |
NCT05485103 | Recruiting | N/A | A Prospective Study of the Effect of Modified Colonoscopy Bowel Preparation Program on Intestinal Cleaning, Examination and Disease in Patients With Inflammatory Bowel Disease | September 1, 2022 | December 31, 2024 |
NCT05515003 | Recruiting | N/A | The Effect of Patient Education on Fatigue in Inflammatory Bowel Disease | June 1, 2020 | October 30, 2022 |
NCT05519904 | Recruiting | Prevalence of Encephalopathy in Patients With Inflammatory Bowel Diseases | October 1, 2022 | August 31, 2023 | |
NCT05530746 | Recruiting | Study on the Diagnostic Value of Multi-omics Combined Detection for Precancerous Lesions of CRC | May 1, 2022 | May 31, 2023 | |
NCT05536544 | Recruiting | N/A | The Inflammatory Bowel Disease Mediterranean Diet (IBDMED) Microbiome-targeting Nutritional Education Program | September 1, 2022 | December 2024 |
NCT05536817 | Recruiting | Sleep Disorder in Inflammatory Bowel Disease and Its Association With Disease Activity | February 5, 2021 | February 2024 | |
NCT05553704 | Recruiting | Phase 2 | Metformin in Patients With Ulcerative Colitis Treated With Mesalamine | November 1, 2022 | December 20, 2025 |
NCT05558761 | Recruiting | Phase 2 | Pentoxifylline as Adjunctive Therapy in Patients With Ulcerative Colitis | October 10, 2022 | February 20, 2025 |
NCT05561062 | Recruiting | Phase 2 | Atorvastatin in Patients With Ulcerative Colitis | December 1, 2022 | June 20, 2027 |
NCT05562726 | Recruiting | Pregnancy in Greek Female Patients With Inflammatory Bowel Disease - Panhellenic Recording | January 1, 2020 | July 1, 2024 | |
NCT05567068 | Recruiting | Phase 2 | Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis | February 1, 2023 | September 20, 2027 |
NCT05570617 | Recruiting | N/A | Transition to Adulthood Through Coaching and Empowerment | November 21, 2022 | August 2024 |
NCT05574387 | Recruiting | Phase 2 | Metformin as Added on Therapy in Patients With Ulcerative Colitis | January 20, 2023 | April 2027 |
NCT05575505 | Recruiting | Phase 2 | Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis. | February 2, 2023 | February 2026 |
NCT05576402 | Recruiting | Endoscopic Scoring System Utilization in Inflammatory Bowel Disease | May 2, 2022 | February 20, 2023 | |
NCT05581420 | Recruiting | N/A | Oral Versus Intravenous Iron in IBD Patients With Anti-inflammatory Therapy. | June 2, 2022 | May 2025 |
NCT05584735 | Recruiting | Determining the Relationship Between Gut Microbiota and Immune Response to Influenza or COVID-19 Vaccine | November 3, 2023 | September 2024 | |
NCT05587673 | Recruiting | Phase 1 | High Dose Steroid Therapy to Treat Flares in Patients With Inflammatory Bowel Disease (IBD) | October 6, 2022 | December 2026 |
NCT03558048 | Recruiting | The Effect of IBD Flares on Serum PSA | August 1, 2019 | October 1, 2025 | |
NCT05598489 | Recruiting | Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel Disease | December 7, 2022 | July 31, 2024 | |
NCT03571373 | Recruiting | PIBD-SETQuality: the Inception Cohort and Safety Registry | January 3, 2017 | December 31, 2025 | |
NCT03589183 | Recruiting | Gut Microbiome in Inflammatory Bowel Disease | April 1, 2018 | March 31, 2028 | |
NCT05602116 | Recruiting | Phase 1 | ASC - Autism Study | June 9, 2023 | February 1, 2026 |
NCT03591770 | Recruiting | Phase 4 | Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib | July 31, 2019 | December 2024 |
NCT05611671 | Recruiting | Phase 2 | A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC | October 31, 2022 | July 2025 |
NCT05615779 | Recruiting | N/A | Personalized B-fructan Diet in Inflammatory Bowel Disease Patients | August 1, 2023 | September 1, 2025 |
NCT05628701 | Recruiting | N/A | Colectomy Reconstruction for Ulcerative Colitis, Ileorectal Anastomosis vs Ileal Pouch-Anal Anastomosis in Ulcerative Colitis. | April 4, 2017 | December 31, 2029 |
NCT06351124 | Recruiting | Phase 1/Phase 2 | Beta-Hydroxybutyrate Feasibility Treating IBD | May 15, 2024 | December 31, 2025 |
NCT05651542 | Recruiting | N/A | A Comprehensive Self-Management Intervention for Individuals With Inflammatory Bowel Disease | March 14, 2023 | March 31, 2025 |
NCT05653011 | Recruiting | Predictors of Prognosis in IBD Patients | March 11, 2013 | December 31, 2024 | |
NCT05657197 | Recruiting | N/A | The Effect of Intensive Physical Exercise on Fatigue and Quality of Life in Patients With Quiescent Inflammatory Bowel Disease | January 10, 2023 | December 2025 |
NCT05673278 | Recruiting | Non-Invasive Monitoring Through Bowel Ultrasound in Paediatric Inflammatory Bowel Disease Study | May 1, 2023 | May 1, 2024 | |
NCT05701501 | Recruiting | N/A | Clinical Study of Vitamin B5 in Adjuvant Treatment of IBD | February 1, 2023 | February 1, 2024 |
NCT05704413 | Recruiting | Digestive Biobank for Exploring Microbiota-host Interactions | June 17, 2021 | September 17, 2026 | |
NCT03787771 | Recruiting | The Fecal Microbiota Transplantation Registry | July 2, 2017 | November 2046 | |
NCT05714566 | Recruiting | Research on Gut Microbiome and Metabolomics Alterations in C.Difficile Infected IBD Patients | November 7, 2022 | December 30, 2024 | |
NCT05719389 | Recruiting | EFFICACY AND SAFETY OF S.C. INFLIXIMAB IN PATIENTS SWITCHED FROM I.V. FORMULATION OF INFLIXIMAB | September 14, 2022 | April 20, 2025 | |
NCT03809728 | Recruiting | N/A | IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN INFLAMMATORY BOWEL DISEASE | December 10, 2019 | December 10, 2034 |
NCT03813862 | Recruiting | Observational Pharmaco-Epidemiology Research & Analysis | December 1, 2013 | November 2027 | |
NCT05719402 | Recruiting | Quantitative Assessment of Intestinal Motility on Bowel Ultrasound in Patients With Inflammatory Bowel Disease: a Feasibility, Observational, Cross-sectional, Monocentric Study | December 15, 2022 | November 25, 2024 | |
NCT05722236 | Recruiting | N/A | IBD Strong Peer2Peer for Self-Management of Psychological Distress | June 1, 2023 | March 2025 |
NCT05722353 | Recruiting | N/A | IBD Disease Course of Infliximab-naïve IBD Patients Treated With Subcutaneous Infliximab CT-P13 Remsima® | February 13, 2023 | February 2026 |
NCT03840928 | Recruiting | PatientSpot Formerly Known as ArthritisPower | April 1, 2015 | March 1, 2025 | |
NCT03843385 | Recruiting | Phase 3 | Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis | January 31, 2023 | July 2026 |
NCT03847467 | Recruiting | Phase 1/Phase 2 | Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy | September 20, 2019 | March 2027 |
NCT03855657 | Recruiting | Biobank - Investigating the Gut Microbiota, Genetics, Epigenetics and Metabolites | March 2014 | July 2034 | |
NCT06392061 | Recruiting | N/A | Effect of Probiotic Administration on Patients With Inflammatory Bowel Disease | April 1, 2024 | June 30, 2024 |
NCT03885713 | Recruiting | Phase 4 | Identification of Predictive Biomarkers for Response to Biologic Therapies and Tofacitinib in Inflammatory Bowel Disease | September 10, 2019 | December 31, 2024 |
NCT03894228 | Recruiting | Safety of IBD Drugs During Pregnancy and Breastfeeding: Mothers and Babies' Outcomes (DUMBO Registry) | May 21, 2019 | March 1, 2028 | |
NCT05733702 | Recruiting | Clinnova-IBD, a Prospective Cohort of Patients With Inflammatory Bowel Disease (IBD) | February 1, 2024 | November 2029 | |
NCT03917303 | Recruiting | Phase 4 | Control Crohn Safe Trial | December 23, 2019 | September 2026 |
NCT03944447 | Recruiting | Phase 2 | Outcomes Mandate National Integration With Cannabis as Medicine | December 1, 2018 | December 31, 2025 |
NCT05753267 | Recruiting | Phase 2/Phase 3 | Fenofibrate in Ulcerative Colitis | February 28, 2023 | June 20, 2025 |
NCT05760729 | Recruiting | Cognitive Impairment and Affective Mood Disorders in Patients With IBD | October 1, 2021 | May 30, 2025 | |
NCT03953768 | Recruiting | N/A | VNS Prospective Neuromodulation of Autonomic, Immune and Gastrointestinal Systems | April 1, 2021 | December 14, 2026 |
NCT04456400 | Suspended | Enhancing Ultrasound & Photoacoustic for Recognition of Intestinal Abnormalities | February 3, 2021 | April 2024 | |
NCT04898530 | Suspended | Diet Patterns in IBD in Central Texas | June 8, 2021 | December 31, 2024 | |
NCT04306939 | Suspended | Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study | November 1, 2014 | December 1, 2025 | |
NCT04225819 | Suspended | N/A | Adjunctive Treatment With Vitamin D3 in Patients With Active IBD | October 1, 2020 | April 1, 2027 |
NCT04143490 | Suspended | N/A | Effects of Exercise in Patients With Ulcerative Colitis | November 4, 2019 | December 2025 |
NCT04100291 | Terminated | N/A | Faecal Microbiota Transplantation in the Treatment of Chronic Pouchitis | July 1, 2019 | March 1, 2022 |
NCT03841942 | Terminated | N/A | Comparison of Trough Level- and Clinical-based Spacing of Infliximab Infusions in Patients With IBD in Deep Remission | June 26, 2019 | October 31, 2023 |
NCT03376230 | Terminated | Role of the Chemical Environment in the Pathogenesis of Inflammatory Bowel Disease | February 2010 | January 24, 2019 | |
NCT03604536 | Terminated | Individualization Treatment Through a Self-managed Web-based Solution in Ulcerative Colitis | December 2, 2019 | December 31, 2021 | |
NCT03827109 | Terminated | N/A | Peer Mentoring to Improve Self-management in Youth With IBD | June 12, 2019 | March 1, 2024 |
NCT03378388 | Terminated | A Study to Assess the Effectiveness and Safety of Treatment With Vedolizumab in Adult Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real Life | February 13, 2018 | February 15, 2019 | |
NCT05461014 | Terminated | N/A | RxWell in Pediatric IBD for Disease Management and Transition Readiness | July 30, 2022 | March 8, 2023 |
NCT03259659 | Terminated | Autonomic and Cytokines Profiles of Patients With Ulcerative Proctitis | November 30, 2017 | February 29, 2020 | |
NCT03139032 | Terminated | Phase 2 | Efficacy and Safety of Etrasimod (APD334) in Inflammatory Bowel Disease Patients With Active Skin Extra-intestinal Manifestations | July 17, 2017 | December 6, 2017 |
NCT03752372 | Terminated | Microbiome Alterations in IL10RA-deficient Patients After HSCT | October 1, 2017 | February 28, 2020 | |
NCT00237653 | Terminated | Phase 3 | MICI-CMV:Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus | February 2004 | December 2007 |
NCT03115749 | Terminated | N/A | Intestinal Mesenchymal Stem Stells and Inflammatory Bowel Diseases | November 21, 2018 | February 13, 2019 |
NCT04956159 | Terminated | Phase 2 | TMS in Inflammatory Bowel Disease | November 1, 2021 | October 7, 2022 |
NCT00360022 | Terminated | N/A | Transition of Inflammatory Bowel Disease (IBD) Patients From Pediatric to Adult Gastroenterologist (GI) | August 2006 | February 2011 |
NCT03329885 | Terminated | Phase 1/Phase 2 | A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis | November 2, 2017 | June 26, 2018 |
NCT04626947 | Terminated | Phase 4 | Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD). | October 30, 2021 | May 31, 2024 |
NCT02945488 | Terminated | N/A | Exercise and Nutrition in IBD & Preconception | August 2016 | September 2017 |
NCT00205062 | Terminated | Phase 4 | Positron Emission Tomography (PET)-Computed Tomography (CT) in Inflammatory Bowel Disease (IBD) | October 2004 | August 2008 |
NCT03107390 | Terminated | N/A | Evaluation of NT-proBNP in Chronic Inflammatory Bowel Disease | October 28, 2013 | August 7, 2017 |
NCT05049525 | Terminated | Phase 2 | Evaluation of the Response of Itraconazole and Terbinafine Therapy in Subjects With Crohn's Disease | February 22, 2022 | February 28, 2024 |
NCT02566889 | Terminated | Phase 4 | An Efficacy and Safety Study of Infliximab Dose Escalation in Pediatric Participants With Inflammatory Bowel Disease | April 2016 | July 2019 |
NCT03798405 | Terminated | N/A | Reactive vs. Proactive Pain Control in IBD | January 1, 2019 | July 1, 2022 |
NCT03358407 | Terminated | Phase 1 | GSK2983559 First Time in Human Study | January 11, 2018 | February 19, 2019 |
NCT03451253 | Terminated | N/A | Effects of an Amino Acid Mixture on Gastrointestinal Function, Inflammation and Fluid Balance: A Pilot Study in Patients With Inflammatory Bowel Disease | April 12, 2018 | March 23, 2021 |
NCT05769829 | Terminated | ImmuneSense™ IBD Study | October 31, 2022 | August 14, 2023 | |
NCT03370601 | Terminated | N/A | Evaluation of the Clinical and Immunological Impact of Two Therapeutic Strategies in Chronic Inflammatory Diseases | January 3, 2017 | January 2019 |
NCT03218202 | Terminated | Stricture Definition and Treatment (STRIDENT) Observational Study. | October 9, 2017 | August 29, 2019 | |
NCT01062919 | Terminated | N/A | Local Anesthetic Wound Infusion and Functional Recovery After Colon Surgery | July 2009 | October 2013 |
NCT03375424 | Unknown status | Vedolizumab Study With Inflammatory Bowel Disease Patients in Germany | October 2, 2017 | April 30, 2024 | |
NCT04734496 | Unknown status | Evaluation of the Mechanisms of Sarcopenia in Chronic Inflammatory Disease: Protocol for a Prospective Cohort Study | January 1, 2019 | September 1, 2021 | |
NCT04750135 | Unknown status | Phase 2 | Assessment of Metformin as Adjuvant Therapy in Patients With Ulcerative Colitis | February 7, 2021 | June 1, 2021 |
NCT02858557 | Unknown status | N/A | The Effect of Diet on Microbial Profile and Disease Outcomes in Patients With Inflammatory Bowel Diseases | September 2016 | September 2018 |
NCT04761952 | Unknown status | N/A | N-3 Polyunsaturated Fatty Acids Prevent Postoperative Recurrence of Crohn's Disease | February 13, 2021 | December 31, 2023 |
NCT04769258 | Unknown status | Effectiveness and Safety of COVID-19 Vaccine in Patients With IBD Treated With Immunomodulatory or Biological Drugs (ESCAPE-IBD) | March 1, 2021 | June 1, 2022 | |
NCT03399188 | Unknown status | N/A | Fecal Microbiota Transplantation and Analysis of Fecal Microbiome in IBD Patients | November 15, 2017 | December 31, 2023 |
NCT03415919 | Unknown status | Collection of Gastrointestinal Malignant and Non-malignant Human Samples | July 13, 2018 | July 2022 | |
NCT03434639 | Unknown status | Fluorescence Spectroscopy for Gut Permeability Assessment | March 29, 2019 | September 30, 2021 | |
NCT03436966 | Unknown status | Role of Multislice CT in Diagnosis of Inflammatory Bowel Disease | October 2018 | October 2019 | |
NCT04587141 | Unknown status | Phase 3 | Clinical Burden of Anemia in Inflammatory Bowel Disease: Therapeutic Trial | January 1, 2020 | June 30, 2023 |
NCT04100239 | Unknown status | N/A | A Pilot and Feasibility Trial of a Group Mindfulness and Self-compassion Intervention for Young People Diagnosed With IBD | November 1, 2019 | September 30, 2023 |
NCT04848649 | Unknown status | N/A | Shortening Treatments Of Chronic Inflammatory Conditions | April 2021 | April 2024 |
NCT04849936 | Unknown status | A Diagnostic Accuracy Study Testing Fecal Biomarkers In Comparison To Endoscopic Examination | July 13, 2020 | August 2023 | |
NCT04085211 | Unknown status | Image-Enhanced Endoscopy in the Gastrointestinal Tract | July 1, 2019 | May 2022 | |
NCT02629211 | Unknown status | N/A | Initial Experience With a Novel Single-Balloon Enteroscopy System in Children With IBD | June 2016 | February 2017 |
NCT03456206 | Unknown status | Chronic Inflammatory Disease, Lifestyle and Risk of Disease | November 10, 2018 | May 1, 2023 | |
NCT04558658 | Unknown status | Neutrophil to Lymphocyte Ratio in Inflammatory Bowel Disease | December 2020 | January 2022 | |
NCT04888299 | Unknown status | N/A | Artificial Intelligence System Based on Raman Spectroscopy in Inflammatory Bowel Disease | April 14, 2021 | April 2023 |
NCT04082559 | Unknown status | N/A | Biomarker-based Multidisciplinary Team (Bio-MDT) Approach to Personalized Microbial-targeted Treatment of Pouchitis and Crohn's Disease | June 11, 2019 | June 11, 2023 |
NCT04893928 | Unknown status | Role of Information and Communication Technologies for Health Support in Inflammatory Bowel Diseases: The DAMASCO Trial | May 3, 2021 | April 30, 2022 | |
NCT04896203 | Unknown status | Hypercoagulability Study Using Haemostatic Techniques in Patients With Inflammatory Bowel Disease | November 18, 2020 | February 15, 2022 | |
NCT03778918 | Unknown status | The Comparison Between the Biomarkers in Inflammatory Bowel Disease Patients and General Control Group | August 1, 2016 | December 30, 2020 | |
NCT04904224 | Unknown status | N/A | Diagnosis of Inflammatory Bowel Disease by Examining the Entire Bowel by Pan-intestinal Capsule Endoscopy | March 7, 2021 | March 31, 2023 |
NCT03464474 | Unknown status | N/A | Digital Holographic Microscopy: Evaluation of Histological Disease Activity in Patients With Ulcerative Colitis | April 1, 2018 | October 1, 2019 |
NCT03465215 | Unknown status | N/A | Evaluation of Stricturing Crohn's Disease Using Digital Holographic Microscopy | February 1, 2018 | August 1, 2020 |
NCT03952364 | Unknown status | The PRECIOUS Study: Predicting Crohn's & ColitIs Outcomes in the United States | October 10, 2019 | June 2022 | |
NCT04946448 | Unknown status | N/A | COmbinAtion Therapy of dieT With biologicalS for Crohn's Disease: the OATS Study | September 14, 2021 | September 30, 2023 |
NCT03486652 | Unknown status | Rheumatological Manifestations in Inflammatory Bowel Diseases | May 1, 2018 | April 1, 2019 | |
NCT04952558 | Unknown status | Delayed Diagnostic Time& Inflammatory Bowel Diseased Patients | July 1, 2021 | March 1, 2022 | |
NCT02560727 | Unknown status | To Evaluate the Feasibility, Safety, and Efficacy of TET for FMT Via Colonic Approach | October 2014 | October 2016 | |
NCT03042091 | Unknown status | Early Phase 1 | Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery | September 2016 | October 2021 |
NCT03496246 | Unknown status | N/A | Vitamin D Status in Inflammatory Bowel Disease | April 2018 | June 2019 |
NCT01242163 | Unknown status | Application of Chemical Sensors for Diagnosis of Inflammatory Bowel Diseases and Irritable Bowel Syndrome by Respiratory Samples | December 2010 | December 2012 | |
NCT04552158 | Unknown status | N/A | Nutritional Assessment and Impact of the Mediterranean Diet on Patients With Inflammatory Bowel Disease | October 2021 | December 2022 |
NCT04976491 | Unknown status | Based on the Special Disease Management of Crohn's Disease Diet Studies | August 1, 2020 | December 1, 2023 | |
NCT04982172 | Unknown status | Phase 4 | Model-informed Dose De-escalation of Infliximab in Patients With Inflammatory Bowel Diseases | February 2022 | February 2023 |
NCT03500653 | Unknown status | N/A | Curcumin Supplementation as an Add on Treatment for Patients With Inflammatory Bowel Diseases Treated With Vedolizumab | June 9, 2020 | December 2022 |
NCT04020835 | Unknown status | Understanding Abdominal Pain in IBD and IBS | May 20, 2019 | March 31, 2020 | |
NCT02044952 | Unknown status | Phase 2/Phase 3 | Efficacy and Safety Study of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction Remission | January 2014 | July 2016 |
NCT04794465 | Unknown status | Asymptomatic Inflammatory Bowel Disease in Catalonia | April 1, 2021 | October 31, 2021 | |
NCT05376228 | Unknown status | A Systems Biology Approach for Identification of Host and Microbial Mechanisms and Druggable Targets for the Treatment of PSC-IBD | February 1, 2022 | April 1, 2023 | |
NCT04109300 | Unknown status | N/A | Preemptive HLA Genotyping for the Safe Use of Infliximab-combination Therapy in Inflammatory Bowel Disease | September 1, 2020 | September 1, 2023 |
NCT03148028 | Unknown status | Immunological Characteristics of Patients With PID and IBD | May 15, 2017 | December 31, 2020 | |
NCT04282577 | Unknown status | Urinary Biomarkers of Renal Injury in Inflammatory Bowel Disease | March 1, 2020 | December 1, 2021 | |
NCT03893942 | Unknown status | Psychological Predictors in Colorectal IBD Surgery Recovery | April 16, 2019 | April 2021 | |
NCT04272307 | Unknown status | MIcroorganisms as Triggers in Acute Severe Ulcerative Colitis and Their Influence on Medical Therapy Efficacy: a Multi-omics Pilot Approach. | May 14, 2020 | February 2022 | |
NCT03843697 | Unknown status | N/A | A Trial for Prevention of Loss of the Effect of Biological Drugs in Patients With Inflammatory Bowel Disease | March 1, 2019 | January 1, 2020 |
NCT03172000 | Unknown status | N/A | Detection of Helicobacter Pylori in Ulcerative Colitis Patients | March 1, 2017 | December 2019 |
NCT04230603 | Unknown status | N/A | Tissue Characterization With Hyperspectral Imaging (HSI) | June 6, 2019 | June 2, 2022 |
NCT03204136 | Unknown status | Tacrolimus Versus Methotrexate as Rescue Therapy for Refractory Inflammatory Bowel Disease | July 1, 2017 | December 1, 2019 | |
NCT03220841 | Unknown status | Phase 4 | Stricture Definition and Treatment (STRIDENT) Drug Therapy Study | October 9, 2017 | September 2021 |
NCT03222011 | Unknown status | N/A | Stricture Definition and Treatment (STRIDENT) Endoscopic Therapy Study | October 9, 2017 | February 2021 |
NCT04225650 | Unknown status | Prevalence of Respiratory Impairment During IBD | May 1, 2020 | August 2020 | |
NCT04189692 | Unknown status | Evolution of Fatigue in Patients With Inflammatory Bowel Disease | January 7, 2020 | December 7, 2020 | |
NCT04105348 | Unknown status | Diabetes Mellitus and Inflammatory Bowel Disease | October 1, 2019 | October 2021 | |
NCT03700593 | Unknown status | Feasibility and Safety of Single Port Robot in Colorectal Procedures | October 15, 2018 | December 31, 2020 | |
NCT03715673 | Unknown status | Von Willebrand Antigen and Activity as Novel Biomarkers of Hemostasis in Inflammatory Bowel Disease | October 1, 2019 | December 2020 | |
NCT04180345 | Unknown status | Development of a Questionnaire Based on Patients' Messages on an Internet Forum for Flare Detection in IBD | January 2020 | February 2021 | |
NCT02912780 | Unknown status | Introduction of Microsystems in a Level 3 Neonatal Intensive Care Unit | January 2013 | December 2017 | |
NCT04179201 | Unknown status | Study on Clostridium Difficile Infection in Chinese Patients With Inflammatory Bowel Disease | September 13, 2017 | September 2020 | |
NCT03719209 | Unknown status | N/A | Using Virtual Reality for Patients With Gastrointestinal Disease | September 1, 2017 | October 2019 |
NCT03055130 | Unknown status | HPV Infection and Cervical Neoplasm in Women With Inflammatory Bowel Disease: a Cross-sectional Study | July 2015 | July 2017 | |
NCT03282786 | Unknown status | N/A | Comparison of Carbon Dioxide (CO2) to Air Insufflation in Colonoscopy in Patients With Inflammatory Bowel Disease | September 3, 2017 | January 31, 2022 |
NCT03299413 | Unknown status | Phase 1/Phase 2 | Use of Mesenchymal Stem Cells in Inflammatory Bowel Disease | June 5, 2017 | January 2020 |
NCT03860012 | Unknown status | Phase 4 | Folic Acid in Pediatric Inflammatory Bowel Disease | September 11, 2018 | May 1, 2020 |
NCT03308357 | Unknown status | Comparison of the Performance of SB2-Infliximab With Originator Infliximab in the Measure of Serum Concentrations in Serum | October 2017 | March 2018 | |
NCT03327038 | Unknown status | N/A | Addressing Depression and Anxiety Symptoms in Patients With Inflammatory Bowel Disease | January 1, 2018 | January 1, 2020 |
NCT03348852 | Unknown status | Phase 2/Phase 3 | Association Between Functional Changes in the Brain and the Perception of Pain in Patients With Inflammatory Bowel Diseases (IBD) - Measured With Functional Magnetic Resonance Imaging. | January 24, 2017 | December 30, 2022 |
NCT03351972 | Unknown status | Phase 4 | Differences in Preparation for Small Bowel Capsule Endoscopy | November 23, 2017 | December 1, 2021 |
NCT04170192 | Unknown status | Multi-center Clinical Study of Cord Blood Stem Cell Transplantation for IBD Caused by IL-10R Gene Deficiency | December 1, 2019 | October 31, 2023 | |
NCT04654494 | Unknown status | Colorectal Cancer in Crohn's Disease | July 1, 2020 | January 2021 | |
NCT04631965 | Unknown status | Healthcare Transition of Adolescents With Chronic Health Conditions | September 1, 2017 | December 2023 | |
NCT03629379 | Unknown status | Phase 4 | Response to Ustekinumab for Anti-tnf Induced Psoriasiform Skin Lesions | September 1, 2018 | July 1, 2021 |
NCT03633409 | Unknown status | Differential EBI2 Expression Upon Allelic Status of the rs9557195 Polymorphism | November 1, 2017 | December 1, 2018 | |
NCT05271838 | Unknown status | N/A | Protein and Magnesium in Ulcerative Colitis | February 8, 2022 | July 1, 2022 |
NCT05277662 | Unknown status | N/A | Precision Diagnostics of Functional and Organic Intestinal Pathology Based on Cellular and Molecular Profiling | October 1, 2021 | May 15, 2023 |
NCT03640637 | Unknown status | The Role of PET/MRI in the Diagnosis and Treatment of Children and Adolescents With Inflammatory Bowel Diseases | October 18, 2018 | August 2021 | |
NCT01590043 | Unknown status | Identifying Saliva Markers in Inflammatory Bowel Disease | May 2012 | ||
NCT02931799 | Unknown status | N/A | Prevention of Readmissions at IBD Centres of Excellence | October 1, 2018 | December 2021 |
NCT05321485 | Unknown status | N/A | The Effect of MedicijnWijs on Adherence to Azathioprine Therapy in Adolescents With IBD | March 16, 2022 | September 16, 2022 |
NCT04286659 | Unknown status | Receptor for Advanced Glycation End Products (RAGE) Polymorphisms In Inflammatory Bowel Disease | March 1, 2020 | December 2023 | |
NCT04284878 | Unknown status | Lymphoid Tyrosine Phosphatase Gene Polymorphisms in Inflammatory Bowel Disease | May 1, 2020 | September 2021 | |
NCT05350644 | Unknown status | Inflammatory Bowel Disease(IBD), Treatment Response | February 8, 2022 | January 14, 2024 | |
NCT05351034 | Unknown status | N/A | The Role of High-resolution Anorectal Manometry in the Diagnosis of Functional Anorectal Disorders in Patients With Inactive Inflammatory Bowel Disease | June 2022 | April 2024 |
NCT03091309 | Unknown status | N/A | Counseling to Optimize Adherence in Expectant Mothers With Inflammatory Bowel Disease | October 1, 2017 | October 1, 2020 |
NCT03889808 | Unknown status | Seroprevalence of Anti-bodies Against Clostridium Difficile Toxins and Prevalence of Asymptomatic Carriage of Clostridium Difficile in IBD Patients. | March 2014 | December 2021 | |
NCT02806206 | Unknown status | Phase 4 | Prucalopride Prior to Small Bowel Capsule Endoscopy | July 2016 | May 2017 |
NCT04079335 | Unknown status | A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Relapse in Patients With IBD | January 28, 2019 | January 28, 2021 | |
NCT05043818 | Unknown status | A Clinical Study on the Screening of Intestinal Biomarkers in IBD Patients With Depression | September 2021 | September 2022 | |
NCT05079932 | Unknown status | Pilot Study for the Evaluation of Food Choices in Patients With Inflammatory Bowel Diseases (MICI2021) | April 1, 2021 | May 31, 2024 | |
NCT05096897 | Unknown status | Oral Health-related Quality of Life (OHRQoL) in Patients With Inflammatory Bowel Disease (IBD) | November 2022 | November 2023 | |
NCT04488471 | Unknown status | Impact of Isolation in Patients With IBD During the COVID-19 Crisis | June 30, 2020 | June 30, 2022 | |
NCT03868332 | Unknown status | Predictors of Subclinical Atherosclerotic Cardiovascular Diseases (ASCVD) in Patients With Inflammatory Bowel Disease | July 20, 2019 | March 20, 2021 | |
NCT03540784 | Unknown status | N/A | Effects of WB-EMS and High Protein Diet in IBD Patients | October 1, 2013 | September 30, 2019 |
NCT04404517 | Unknown status | Phase 3 | Correlation of Serum Adalimumab Levels at an Administration of 40 mg Weekly vs 80 mg Every Two Weeks | October 1, 2019 | October 30, 2021 |
NCT05150548 | Unknown status | Predictive Time-to-Event Model for Major Medical Complications After Colectomy | December 1, 2021 | December 31, 2022 | |
NCT05151458 | Unknown status | Serum NGAL as a Predictor of Clinical and Endoscopic Activity of Inflammatory Bowel Disease | December 29, 2021 | November 30, 2022 | |
NCT05157750 | Unknown status | Endoscopic Remission, Histologic Remission and Barrier Healing for Predicting Disease Behaviour in IBD | January 16, 2017 | May 1, 2022 | |
NCT03872726 | Unknown status | Development and Validation of a Self-reported Objective Index of Work Disability in Inflammatory Bowel Disease | March 1, 2019 | May 30, 2019 | |
NCT03884686 | Unknown status | N/A | Promote Food. Improving Food-related Quality of Life in Inflammatory Bowel Disease | December 16, 2018 | April 2019 |
NCT03825900 | Unknown status | Phase 3 | Transcranial Direct Current Stimulation and the Interaction Between Chronic Pain and the Intestinal Epithelial Barrier in Patients With Chronic Inflammatory Bowel Diseases (IBD) | June 1, 2018 | December 30, 2022 |
NCT04138225 | Unknown status | The Ecological Role of Yeasts in the Human Gut | September 23, 2018 | September 23, 2021 | |
NCT04330105 | Unknown status | Subclinical Cardiac Involvement in Patients With Inflamatory Bowel Disease | May 1, 2020 | July 30, 2022 | |
NCT04329481 | Unknown status | N/A | The Effect of Mycobiome Supplementation on Gastrointestinal Symptoms in IBD Patients | June 12, 2018 | June 12, 2024 |
NCT05174754 | Unknown status | N/A | Response To Medical Therapy in Inflammatory Bowel Disease Patients Carrying-out a Prescribed Exercise Programme | August 30, 2022 | May 22, 2023 |
NCT03576027 | Unknown status | N/A | Hyperbaric Oxygen Therapy in Children With Inflammatory Bowel Diseases | May 21, 2018 | December 31, 2021 |
NCT05182996 | Unknown status | N/A | Perceptions and Barriers About Cessation of Smoking Among IBD Patients | August 15, 2021 | October 1, 2022 |
NCT03885479 | Unknown status | Impact of Different Dietary IgGs on the Pathogenesis of IBD | April 1, 2019 | March 31, 2020 | |
NCT03833310 | Unknown status | Novel Biomarkers in Inflammatory Bowel Disease | January 1, 2021 | January 30, 2024 | |
NCT02027727 | Unknown status | Individualized Infiximab Dosing-Proof of Concept Study | November 2013 | March 2018 | |
NCT04067934 | Unknown status | N/A | JUMP Inflammatory Bowel Disease Study | August 2019 | July 2021 |
NCT04324632 | Unknown status | Magnetic Resonance Enterography in Inflammatory Bowel Diseases | April 2020 | April 2022 | |
NCT03593252 | Unknown status | N/A | Bowel Preparation in Elective Pediatric Colorectal Surgery | January 1, 2022 | January 30, 2024 |
NCT01914445 | Unknown status | N/A | Chromoendoscopy of the Colon After Oral Administration of Indigo Carmine | August 2013 | December 2013 |
NCT05223452 | Unknown status | Role of Ultrasound in Inflammatory Bowel Disease | May 1, 2022 | July 2023 | |
NCT03615287 | Unknown status | Assessing Cardiovascular Dysfunction Pre- & Post-treatment in Inflammatory Bowel Diseases | January 26, 2018 | January 2022 | |
NCT03529318 | Withdrawn | Mucosal Innate Immune Activation in Chronic Intestinal Disorders | September 1, 2018 | October 18, 2019 | |
NCT00573846 | Withdrawn | Phenotypic Characteristics of Inflammatory Bowel Disease in Southeast Asian Population - A Multi-centered US Study | July 2007 | October 2008 | |
NCT03333148 | Withdrawn | Early Phase 1 | Preoperative Oral ImmunoNuTrition to Improve Surgical Outcomes for IBD Patients (PINT) | June 1, 2020 | January 1, 2022 |
NCT03053414 | Withdrawn | N/A | Vitamin D Repletion and Maintenance in IBD: How Much and How Often | February 20, 2017 | December 1, 2018 |
NCT02281799 | Withdrawn | Phase 4 | Thiopurine Induced Pancreatitis in IBD Patients | March 2015 | January 2018 |
NCT05578508 | Withdrawn | Phase 1 | Stem Cells for the Treatment of Pouchitis | April 2022 | February 2024 |
NCT04794335 | Withdrawn | Visceral Afferents | November 1, 2023 | April 30, 2025 | |
NCT05817266 | Withdrawn | N/A | Role of FCI in the Detection of Proctosigmoiditis Caused by IBD | March 2024 | March 31, 2024 |
NCT03953794 | Withdrawn | Inflammatory Bowel Disease Tracker (IBD Tracker) | October 2019 | February 2021 | |
NCT03467620 | Withdrawn | Phase 2/Phase 3 | Cannabidiol Usage as an Adjunct Therapy for Crohn's Disease | July 2018 | July 2019 |
NCT04202211 | Withdrawn | Phase 2 | FMT for Remission of Active Ulcerative Colitis in Adults | March 2022 | December 2028 |
NCT03886532 | Withdrawn | GI Medical Cannabis Study on IBD | November 1, 2019 | December 31, 2020 | |
NCT03958266 | Withdrawn | MyIBD Care - Feasibility Study | July 2019 | December 2020 | |
NCT03633669 | Withdrawn | N/A | Effect of Real-world Tight Control Management of Inflammatory Bowel Disease | September 1, 2018 | December 31, 2019 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D015212